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A cohort study of workers exposed to the chemical acrylonitrile (AN) was carried-out in 
the late 1980s by the National Cancer Institute (NCI) to determine if there were any excess 
cancer risks associated with workplace exposures to AN.  The results of the study did not show 
any overwhelming evidence that AN exposure was related to increased cancer risk, but did yield 
several results worth noting.  Firstly, the authors reported an overall lung cancer risk of 3.6 for 
ever-smokers versus never-smokers, which appeared to be much too low.  Secondly, there was a 
slight increase in the lung cancer relative risk due to exposure in the upper quintile of cumulative 
AN exposure.  Lastly, there was a large proportion of missing smoking information for the 
employees selected in the sample. 
Because results of occupational cohort studies such as the NCI’s are used as the basis for 
determining health risks associated with workplace exposures and because acrylonitrile is widely 
used in the manufacturing of plastics, it is very important from a public health perspective to 
eliminate any possible sources of confounding or bias.  The goal of this reanalysis is to address 
the issues of missing smoking information and the low overall lung cancer relative risk in ever-
smokers to determine if the slight excess in the highest AN exposure category appears to be 
valid.  This was accomplished using imputation, a procedure that predicts a smoking status for 
iii 
the missings based on complete observations.  The NCI analyses were then repeated with the 
imputed data to see if there were any differences in the overall smoking lung cancer RR or the 
lung cancer RR in the upper quintile of AN exposure. 
The overall lung cancer RR due smoking could not be increased dramatically using the 
weighting schemes in this paper.  Also, the lung cancer RRs in the upper quintile of AN 
exposure were not much lower than those in the original NCI study, so their analysis with the 
missing smoking information does not appear to have been biased.  However, the smoking 
adjusted lung cancer RRs for cumulative AN exposure using the imputed data have a much 
flatter exposure-response trend than the NCI analysis, which, when combined with the only 
slightly elevated RR in the upper exposure group, could be used as evidence against an increased 
lung cancer risk due to high AN exposure. 
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1. INTRODUCTION 
 
 
Acrylonitrile (AN) is a colorless liquid chemical that is most commonly found in organic 
solvents such as acetone, benzene, carbon tetrachloride, ethyl acetate, and toluene.  The largest 
AN users are companies that make acrylic or modacrylic fibers, high impact ABS (acrylonitrile-
butadiene-styrene) plastics and SAN (styrene-acrylonitrile), which is used in automotive 
products, household goods, and packaging materials (EPA).  Acyrlonotrile had also been used as 
a pesticide and tobacco fumigant, but this was discontinued in the late 1970’s (Blair, et al. 1998). 
The primary routes of acrylonitrile exposure are inhalation and contact with the skin 
(EPA).  Because AN does not occur naturally and is rarely found in air, most exposures are 
occupational.  Because of any possible workplace exposure, OSHA, the Occupational Safety and 
Health Administration, which is responsible for the safety and health of the country’s workforce, 
has set allowable exposure limits to acrylonitrile.  The permissible exposure limit (PEL) set by 
OSHA is 2 ppm (parts per million) as an 8 hour time weighted average with no skin or eye 
contact (OSHA).  The short term exposure ceiling (15 minutes) was set at 10 ppm. 
The IARC, the International Agency for Research on Cancer, initiated a program in 1969 
to evaluate the carcinogenic risk of certain chemicals to humans.  These results, published as 
monographs, are prepared under the direction of international groups of experts who evaluate 
and review evidence on the carcinogenicity of certain substances.  Types of information included 
in these monographs are exposure data, review of cancer studies in humans, studies of cancer in 
laboratory animals, evaluation of carcinogenicity and its mechanisms, and a summary and 
evaluation.  The monographs are updated regularly as new information or studies are made 
available.   
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The IARC reports that past acrylonitrile studies have been inconclusive as to the 
relationship between AN exposure and cancer.  Studies from the 1970s and 1980s did indicate a 
possible increase in lung cancer among exposed workers, but had potential design problems such 
as insufficient follow-up time, small sample sizes, lack of exposure data, and possible 
confounding due to smoking.  Conversely, AN exposure tests in laboratory animals produced 
statistically significant results for increases in certain types of malignant and benign tumors.  
Based on reviews of these studies, the IARC evaluation states there is ‘sufficient evidence’ of 
carcinogenicity in laboratory animals.  For humans, there is ‘inadequate evidence’ of 
carcinogenicity.  The ‘inadequate evidence’ classification is based on the insufficient power, 
statistical significance, or quality of the available studies.  The overall evaluation of AN as group 
2B by the IARC means there is insufficient evidence of increased cancer risk in humans, but 
there is sufficient evidence of increased cancer risk in laboratory animals (IARC 1999).  
Similarly, the United States Environmental Protection Agency (EPA) has classified AN as a 
group B1 carcinogen, a probable human carcinogen (EPA). 
Because of the shortcomings if these past studies, the National Cancer Institute (NCI) and 
the National Institute for Occupational Health and Safety (NIOSH) conducted a comprehensive 
cohort study to determine if there were any potential cancer risks due to occupational exposures 
to acrylonitrile.  The results of the study were published by Blair et al. in 1998.  The exposure 
assessment portion of the study was published at the same time by Stewart et al. (1998). 
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1.1. Original NCI Study Cohort 
 
Because the greatest exposures could be expected at plants where acrylonitrile is 
produced, plants or facilities of these types were sought out for inclusion in the study.  The final 
cohort was assembled from 8 different AN plants.  The basic types of AN production at each 
facility were as follows: 4 involved in AN monomer production, 3 produced AN fibers, and 1 
produced AN resin.  All workers employed at any of the 8 study plants were included in the 
cohort.  The workers had to be employed prior to 1984 and after AN production had begun.  All 
demographic and work history information was obtained from company records.  Demographic 
data includes information such as date of birth, date of hire, race, gender, and vital status.  Work 
history data was collected to determine an employee’s work area and job title history, which are 
used in determining an individual’s AN exposure.  Study investigators performed personal 
monitoring of exposures at all 8 plants.  These exposures were linked to an employee’s job title 
and area to determine AN exposure over an entire work history.  The total number of employees 
in the final cohort was 25,460 (Blair et al. 1998). 
Because smoking is known to be a risk factor for lung cancer, it is important to adjust for 
smoking if lung cancer risk due to an occupational exposure is going to be evaluated.  To address 
any possible confounding due to smoking, it is first necessary to determine an employee’s 
smoking history.  Because the costs and time associated with determining the smoking status of 
every individual in the cohort would be prohibitive, the authors chose to collect smoking 
information for a sub-sample of the entire cohort.  Smoking histories are only gathered for 
employees in this sample, saving time and money, and the lung cancer risk due to occupational 
 3
exposures can then be adjusted for smoking.  An analysis of this type is referred to as a case-
cohort design. 
 
1.2. Case-Cohort Design Description  
 
Prentice proposed the case-cohort design in 1986.  In this design, a sample of the entire 
cohort is selected and evaluated for a certain measure, smoking status, for example.  Any 
additional cases that were not selected in this sample would also be evaluated for smoking status.  
The sampled members of the cohort and the additional cases are combined to form a sub-cohort.  
In addition to the demographic variable information that was available for all individuals in the 
full cohort, the individuals in the sub-cohort have the additional smoking status covariate.  The 
sub-cohort is analyzed using a standard Cox proportional hazards model, but with slight 
modification (Prentice 1986; Barlow 1994; Barlow and Ichikawa 1999).  The cases that were 
included in the original sample are used as controls until their failure time.  The cases that were 
not in the original sample are only analyzed as cases at their failure time and never appear as 
controls.  Figure 1 represents a case-cohort design for a cohort of size N with c cases.  The sub-
cohort, n, is selected from the entire cohort, N, with a sampling fraction f = n/N.  The cases 
included in the sub-cohort sample are represented by csc.  The lower figure shows the final size 
of the sub-cohort, which is the sum of the sampled employees, n, and the cases not included in 
the original sample, (c-csc). 
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Figure 1: Case-cohort schematic 
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1.3. NCI Case-Cohort Design 
 
In the NCI study, smoking information was gathered for a 10% sample of the entire 
cohort.  The sample was drawn systematically by selecting employment records for every 10th 
individual after a random starting point was determined.  Employment records for the cases (not 
in the original systematic sample) were also collected.  The lung cancer relative risks (RR) for 
AN exposure, adjusted for smoking, were calculated using EPICURE’s PEANUTS module, 
which analyzes proportional hazards models, specifically case-cohort designs (Blair et al. 1998).  
The schematic for the NCI sub-cohort is shown in Figure 2.   
 
 
Figure 2: Case-cohort schematic for NCI study 
 
 
The sub-cohort size is 2655 employees, with 193 lung cancer cases, 18 of which were selected in 
the systematic sample and are therefore eligible to be controls in the risk sets. 
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1.4. NCI Results 
 
There are several results published in the NCI paper that are of interest.  The reported rate 
ratio for lung cancer in ever- versus never-smokers was 3.6.  This number appears to be very low 
and is atypical of the lung cancer relative risk of 8.0-10.0 observed in ever- versus never-
smokers.  In the U.S. Department of Health and Human Services The Health Consequences of 
Smoking (2004), the relative risk due to smoking in current versus never-smokers is reported as 
approximately 23 in males and 13 in females.  Although this only involves current versus never 
smokers and not the ever- versus never-smoker discussed in the NCI paper, this gives an 
indication of the magnitude of the lung cancer relative risk due to smoking. 
Another of the findings of the NCI paper was an elevated relative risk (RR) of lung 
cancer in the upper quintile of AN exposure.  Although this result was not significant and there 
was no statistically significant relative risk trend through the increasing cumulative AN exposure 
groups, the paper concluded that there may be evidence of “carcinogenic activity at the highest 
levels of exposure.”  Because of the lack of statistical significance, the recommendation was 
additional follow-up to determine if there is an increase in lung cancer relative risk in the upper 
cumulative AN exposure groups. 
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Table 1: Lung cancer relative risk by quintile of AN exposure – NCI study results 
 
 
O RR O RR O RR O RR O RR p for trend
Cumulative exposure for full cohort 27 1.1 26 1.3 28 1.2 27 1.0 26 1.5 0.65
Cumulative exposure for full smoking 
subcohort (not adjusted for smoking) 27 0.8 26 1.1 28 1.0 27 0.9 26 1.5 0.70
Cumulative exposure for smoking 
subcohort with information on cigarette 
use (not adjusted for smoking)
5 0.3 6 0.9 7 1.0 13 1.0 9 1.7 0.80
Cumulative exposure for smoking 
subcohort adjusted for ever cigarette use 5 0.3 6 0.8 7 1.0 13 0.9 9 1.6 0.99
Cumulative exposure for smoking 
subcohort adjusted for number of 
cigarettes per day
5 0.3 8 0.7 7 1.1 13 1.0 9 1.7 0.96
Full cohort with RR values adjusted for 
smoking - 1.1 - 1.0 - 1.1 - 0.9 - 1.4 -
O - Observed
RR - Relative risk
Quintile of exposure
1 (lowest) 2 3 4 5 (highest)
 
 
 
Table 1 is reproduced from the NCI study (Blair et al. 1998).  The first row of the table 
shows the elevated lung cancer RR of 1.5 in the upper quintile of AN exposure.  The p-value for 
trend is a non-significant 0.65.  The last row of the table shows the exposure RRs for the full 
cohort adjusted for smoking.  To get this ‘adjusted’ value, the authors calculated the proportional 
change in RR for the sub-cohort (for which smoking information was available) adjusted for and 
not adjusted for smoking.  This proportional change was applied to the values in the first row of 
the table to obtain the values in the last row.  For example, in the 5th quintile of AN exposure, the 
RR for the smoking sub-cohort (not adjusted for smoking) is 1.7.  The RR for the smoking sub-
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cohort adjusted for ever cigarette use is 1.6.  The full cohort with RR adjusted for smoking (last 
row of table) is calculated in Equation 1.4.1. 
4.1
7.1
6.15.1 =×=×= sub
unadj
sub
adjfull
unadj
full
adj RR
RR
RRRR     (Equation 1.4.1.), 
where: 
 
full
unadjRR  is the RR for the full cohort unadjusted for smoking (row 1) 
sub
adjRR  is the RR for the sub-cohort adjusted for smoking (row 4) 
sub
unadjRR  is the RR for the sub-cohort unadjusted for smoking (row 3) 
 
The basis of the paper’s conclusion, the relative risk of 1.5 in the upper quintile of 
exposure, was unadjusted for smoking.  As shown, the relative risk only dropped to 1.4 after 
adjustment.  The authors admit that this result is surprising because the smoking prevalence 
increased by exposure quintile.  Confounding due to smoking, which could be possible, as the 
authors point out, because much of the smoking information was missing, was ruled out for two 
reasons.  Firstly, the adjustment for smoking did not dramatically change the relative risks in the 
AN exposure groups (1.5 to 1.4 in the upper quintile).  The smoking histories, which were 
missing for almost two-thirds of the cases, were dismissed as a possible reason for this slight 
change after adjustment.  The authors noted that because the available information did not 
indicate confounding, there should be no reason to believe that the missing information would be 
any different and show confounding.  Secondly, there were no excess risks noted in other 
diseases related to smoking in the AN exposed individuals, and if there was confounding, it 
would effect the other smoking-related conditions and not just lung cancer. 
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2. STATEMENT OF THE PROBLEM 
 
Two of the issues from the paper will be the focus of this thesis: 
• the low overall lung cancer RR of 3.6 for ever- versus never-smokers 
• the minimal change in the lung cancer RR in the upper quintile of AN exposure after 
adjustment for smoking (1.5 to 1.4)  
By analyzing the smoking histories and systematically allocating those with missing smoking 
information as ever- or never-smokers, it is hoped that the overall lung cancer RR due to 
smoking can be raised to a more realistic level, while at the same time observing an adjusted 
lung cancer RR in the upper AN exposure group less than the reported 1.4. 
 
3. METHODS 
3.1. Reproduction of NCI Results 
 
3.1.1. NCI sub-cohort data files 
Before beginning an analysis of the missing smoking information and reallocating the 
unknowns as ever- or never-smokers, it is necessary to reproduce the results of the NCI paper.  
In 2001, Marsh et al. performed a reevaluation of the lung cancer RRs in the NCI cohort study 
using external rates as the basis for comparison.  To perform the reevaluation, a copy of the 
study data was obtained from the original study authors.  The sub-cohort data was obtained as a 
SAS (SAS Institute Inc. 1999) dataset with 2655 observations (individuals) and 492 variables.  
Information in the dataset includes employee id, vital status, plant, race, sex, smoking status, and 
AN exposure data.  An MS Excel spreadsheet with much of the same information was also 
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obtained.  The SAS dataset will subsequently be referred to as SMK_NCI and the Excel file as 
SMOKECUM. 
 
3.1.2. NCI sub-cohort demographic data 
 
Table 2: Frequency distribution of sub-cohort employees by demographic and exposure variables 
 
Demographic Variable
Race
White 183 (92.9) 183 (88.4) 160 (89.9) 219 (75.0) 715 (92.0) 248 (82.4) 202 (89.8) 416 (87.0) 2326 (87.6)
Nonwhite 14 (07.1) 23 (11.1) 14 (07.9) 71 (24.3) 61 (07.9) 53 (17.6) 23 (10.2) 62 (13.0) 321 (12.1)
Unknown 0 (00.0) 1 (00.5) 4 (02.2) 2 (00.7) 1 (00.1) 0 (00.0) 0 (00.0) 0 (00.0) 8 (00.3)
Gender
Male 169 (85.8) 157 (75.8) 118 (66.3) 201 (68.8) 634 (81.6) 263 (87.4) 206 (91.6) 379 (79.3) 2127 (80.1)
Female 28 (14.2) 50 (24.2) 60 (33.7) 91 (31.2) 143 (18.4) 38 (12.6) 19 (08.4) 99 (20.7) 528 (19.9)
Year of Birth
<1925 30 (15.2) 8 (03.9) 24 (13.5) 29 (09.9) 94 (12.1) 50 (16.6) 17 (07.6) 161 (33.7) 413 (15.6)
1925-1934 43 (21.8) 35 (16.9) 38 (21.3) 47 (16.1) 161 (20.7) 68 (22.6) 37 (16.4) 142 (29.7) 571 (21.5)
1935-1944 74 (37.6) 78 (37.7) 37 (20.8) 71 (24.3) 258 (33.2) 60 (19.9) 75 (33.3) 87 (18.2) 740 (27.9)
1945-1954 41 (20.8) 57 (27.5) 59 (33.1) 100 (34.2) 215 (27.7) 76 (25.2) 77 (34.2) 66 (13.8) 691 (26.0)
>1955 9 (04.6) 29 (14.0) 20 (11.2) 45 (15.4) 48 (06.2) 47 (15.6) 19 (08.4) 22 (04.6) 239 (09.0)
Unknown 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 1 (00.1) 0 (00.0) 0 (00.0) 0 (00.0) 1 (00.0)
AN exposure
Unexposed 40 (20.3) 108 (52.2) 128 (71.9) 33 (11.3) 232 (29.9) 110 (36.5) 37 (16.4) 198 (41.4) 886 (33.4)
Exposed 157 (79.7) 99 (47.8) 50 (28.1) 259 (88.7) 545 (70.1) 191 (63.5) 188 (83.6) 280 (58.6) 1769 (66.6)
<0.13 ppm-yrs 45 (28.7) 33 (33.3) 4 (08.0) 148 (57.1) 184 (33.8) 87 (45.5) 54 (28.7) 100 (35.7) 655 (37.0)
0.13 to 0.57 ppm-yrs 32 (20.4) 32 (32.3) 7 (14.0) 22 (08.5) 89 (16.3) 44 (23.0) 40 (21.3) 62 (22.1) 328 (18.5)
0.57 to 1.5 ppm-yrs 37 (23.6) 13 (13.1) 6 (12.0) 16 (06.2) 67 (12.3) 34 (17.8) 29 (15.4) 51 (18.2) 253 (14.3)
1.5 to 8.0 ppm-yrs 26 (16.6) 12 (12.1) 13 (26.0) 36 (13.9) 103 (18.9) 20 (10.5) 51 (27.1) 55 (19.6) 316 (17.9)
>8.0 ppm-yrs 17 (10.8) 9 (09.1) 20 (40.0) 37 (14.3) 102 (18.7) 6 (03.1) 14 (07.4) 12 (04.3) 217 (12.3)
Total 197 (07.4) 207 (07.8) 178 (06.7) 292 (11.0) 777 (29.3) 301 (11.3) 225 (08.5) 478 (18.0) 2655 (100.0)
Plant 1 Plant 2 Plant 3 Plant 4 Plant 5 Plant 6 Plant 7 Plant 8 Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
 
 
 
 
Table 2 shows how the sub-cohort employees are distributed among the eight plants for 
several demographic variables and exposure histories.  The table shows that the sub-cohort 
employees are predominately white males.  Plant 5 is the largest, accounting for 777 of the 2655 
employees (29.3%).  The other seven plants range from 18% to 7% of the employees in the sub-
cohort.  Workers ever-exposed to AN make-up 67% of the sub-cohort.  Among the exposed, 
37% are from the lowest AN cumulative exposure group, 18.5% from group 2, 14.3% from 
group 3, 18% from group 4, and 12% are from the upper quintile of cumulative AN exposure.  
The cumulative AN exposure cut points are set at 0.13 ppm-years, 0.57 ppm-years, 1.50 ppm-
yrs, and 8.00 ppm-years to match the NCI paper.  Neither the NCI_SMK nor SMOKECUM 
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datasets had variables for the AN cumulative exposure groups, so they had to be determined 
from the exposure data.  The cumulative AN was included in the SMOKECUM file, but had to 
be converted to ppm-years.  Once the cumulative AN was converted to ppm-years, the quintile of 
exposure was assigned to the appropriate group according to the cut points.  Equation 3.1.2.1. 
demonstrates this for an employee whose lifetime cumulative AN was given in the 
SMOKECUM spreadsheet as 85.2 ppm-days. 
 
yearsppm
days
yeardaysppm −=××− 1667.0
7
5
_365
_12.85   (Equation 3.1.2.1.) 
 
This employee would fall into the 2nd quintile of cumulative AN exposure (0.13 to 0.57 ppm-
years).  The 
7
5  multiplier assumes an employee works 5 out of 7 days a week.  The cumulative 
AN exposure calculations are relatively straightforward at this point because only the total AN 
exposure is required, but become more complex when the individual risk-sets must be developed 
at the case failure times because an employee’s cumulative AN exposure group changes with 
time. 
 
3.1.3. NCI sub-cohort distribution of lung cancer cases 
There are 193 lung cancer cases in the entire cohort.  Table 3 shows the distribution of 
the lung cancer cases by race, gender, year of birth, and cumulative AN exposure group. 
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Table 3: Frequency distribution of sub-cohort lung cancer cases by demographic and exposure variables 
 
Demographic Variable
Race
White 8 (88.9) 6 (100.0) 11 (100.0) 23 (92.0) 38 (97.4) 25 (86.2) 10 (100.0) 58 (90.6) 179 (92.7)
Nonwhite 1 (11.1) 0 (00.0) 0 (00.0) 2 (08.0) 1 (02.6) 4 (13.8) 0 (00.0) 6 (09.4) 14 (07.3)
Unknown 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0)
Gender
Male 9 (100.0) 3 (50.0) 10 (90.9) 21 (84.0) 36 (92.3) 29 (100.0) 10 (100.0) 58 (90.6) 176 (91.2)
Female 0 (00.0) 3 (50.0) 1 (09.1) 4 (16.0) 3 (07.7) 0 (00.0) 0 (00.0) 6 (09.4) 17 (08.8)
Year of Birth
<1925 6 (66.7) 1 (16.7) 9 (81.8) 12 (48.0) 16 (41.0) 16 (55.2) 8 (80.0) 47 (73.4) 115 (59.6)
1925-1934 3 (33.3) 2 (33.3) 1 (09.1) 9 (36.0) 16 (41.0) 11 (37.9) 2 (20.0) 16 (25.0) 60 (31.1)
1935-1944 0 (00.0) 2 (33.3) 1 (09.1) 4 (16.0) 7 (17.9) 1 (03.4) 0 (00.0) 0 (00.0) 15 (07.8)
1945-1954 0 (00.0) 1 (16.7) 0 (00.0) 0 (00.0) 0 (00.0) 1 (03.4) 0 (00.0) 0 (00.0) 2 (01.0)
>1955 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 1 (01.6) 1 (00.5)
AN exposure
Unexposed 1 (11.1) 5 (83.3) 7 (63.6) 2 (08.0) 15 (38.5) 9 (31.0) 2 (20.0) 18 (28.1) 59 (30.6)
Exposed 8 (88.9) 1 (16.7) 4 (36.4) 23 (92.0) 24 (61.5) 20 (69.0) 8 (80.0) 46 (71.9) 134 (69.4)
<0.13 ppm-yrs 0 (00.0) 0 (00.0) 0 (00.0) 9 (39.1) 2 (08.3) 4 (20.0) 0 (00.0) 13 (28.3) 28 (20.9)
0.13 to 0.57 ppm-yrs 1 (12.5) 0 (00.0) 0 (00.0) 1 (04.3) 6 (25.0) 6 (30.0) 3 (37.5) 8 (17.4) 25 (18.7)
0.57 to 1.5 ppm-yrs 5 (62.5) 1 (100.0) 0 (00.0) 2 (08.7) 4 (16.7) 7 (35.0) 1 (12.5) 7 (15.2) 27 (20.1)
1.5 to 8.0 ppm-yrs 1 (12.5) 0 (00.0) 0 (00.0) 1 (04.3) 6 (25.0) 2 (10.0) 3 (37.5) 15 (32.6) 28 (20.9)
>8.0 ppm-yrs 1 (12.5) 0 (00.0) 4 (100.0) 10 (43.5) 8 (33.3) 1 (05.0) 1 (12.5) 3 (06.5) 28 (20.9)
Total 9 (04.7) 6 (03.1) 11 (05.7) 25 (13.0) 39 (20.2) 29 (15.0) 10 (05.2) 64 (33.2) 193 (100.0)
Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Plant 5 Plant 6 Plant 7 Plant 8Plant 1 Plant 2 Plant 3 Plant 4
 
 
 
As would be expected, due to the distribution of the sub-cohort employees, the majority of the 
lung cancer cases are white males.  Over 90% (175/193) of the cases occur in employees born 
before 1934.  It is also interesting to note that although Plant 8 accounts for only 18% of the sub-
cohort employees, it accounts for one-third (64/193) of the cases.  In the unexposed workers, 
there are 59 cases.  Table 4 shows the distribution of the 134 exposed cases by cumulative AN 
exposure quintile. 
 
 
Table 4:  Exposed Lung Cancer Cases by Quintile of Cumulative AN Exposure 
 
      lung |                Quintile of AN Exposure 
    cancer |         1          2          3          4          5 |     Total 
-----------+-------------------------------------------------------+---------- 
      case |        28         25         27         28         26 |       134  
    (row %)|     20.90      18.66      20.15      20.90      19.40 |    100.00 
 
 
The lung cancer cases are very evenly distributed among the cumulative AN exposure quintiles.  
If the frequency of cases are compared to those in Table 1 (the NCI study’s Table 9), it can be 
seen that there are 27, 26, 28, 27, and 26 cases in exposure quintiles 1 through 5, respectively.  
The observed deaths are off by one for quintiles 1, 2, 3, and 4.  The SMOKECUM and 
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NCI_SMK data (the original data from NCI) were double-checked and always yielded the 
observed deaths as shown in Table 4.  It appears that the discrepancy may just be with the NCI 
Table 9.  Even slight manipulation of the AN cumulative exposure group cut points will not yield 
observed deaths that match the NCI paper.  The values in Table 4 will be assumed to be correct. 
 
3.1.4. Proportional hazards models to obtain relative risks 
The next step is to run the proportional hazard models to get the overall lung cancer RR 
due to smoking and then to determine the lung cancer RRs by cumulative AN exposure quintile, 
adjusted and unadjusted for smoking.  These values will be compared to the NCI Table 9 to 
ensure that the results are similar.  Because of software availability and advances, SAS (SAS 
Institute Inc. 1999) will be used instead of EPICURE to run the proportional hazards regression 
models.  Ichikawa and Barlow (1998) developed a SAS macro specifically designed to analyze 
case-cohort data that also allows for selection of different weighting schemes, handling of ties, 
stratification, and covariate selection.  The smoking status variable used by the authors to 
determine ever- or never-smoker status will be discussed in the “Smoking Information” section.  
Example SAS code is given in Appendix A.  The results are shown in Table 5. 
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Table 5:  Lung cancer relative risk by quintile of AN exposure – NCI study results and reanalysis 
 
O RRa O RR O RR O RR O RR
NCI 27 0.8 26 1.1 28 1.0 27 0.9 26 1.5
Reanalysis 28 0.91 25 1.10 27 0.98 28 0.97 26 1.54
NCI 5 0.3 6 0.9 7 1.0 13 1.0 9 1.7
Reanalysis 4 0.35 8 0.92 8 0.95 12 1.00 11 1.73
NCI 5 0.3 6 0.8 7 1.0 13 0.9 9 1.6
Reanalysis 4 0.31 8 0.85 8 0.92 12 0.84 11 1.56
NCI 5 0.3 8 0.7 7 1.1 13 1.0 9 1.7
Reanalysis 3 0.28 6 0.72 8 1.07 11 0.95 11 1.78
a RR values adjusted for gender and race
b Quintile cut points at 0.13 ppm-yrs, 0.57 ppm-yrs, 1.50 ppm-yrs, and 8.00 ppm-yrs
Quintile of exposureb
1 (lowest) 2 3 4 5 (highest)
Cumulative exposure for full 
smoking subcohort (not adjusted 
for smoking)
Cumulative exposure for smoking 
subcohort with information on 
cigarette use (not adjusted for 
smoking)
Cumulative exposure for smoking 
subcohort adjusted for ever 
cigarette use
Cumulative exposure for smoking 
subcohort adjusted for number of 
cigarettes per day
 
 
 
3.1.5. Reanalysis comparison to original NCI results 
Overall, the relative risks obtained in the reanalysis agree with those from the NCI study.  
The RRs in the original study are only reported to one decimal place, so the degree of difference 
cannot be calculated exactly, but the results are close enough to rule out any significant problem 
with the modeling in SAS or possible programming errors.  As pointed out in earlier, the 
observed deaths in the reanalysis do not match the NCI study exactly.  The differences are more 
pronounced when the smoking status variable is introduced.  For example, for the ‘cumulative 
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exposure for smoking sub-cohort with information on cigarette use (not adjusted for smoking)’ 
category in the table, there are 40 observed deaths in the NCI study, but 43 in the reanalysis.  The 
reanalysis uses the original data, so it again appears as if the problem may be with the table itself 
and not in the actual data or with data manipulation. 
 
3.2. Sub-cohort Smoking Status Variables 
 
3.2.1. Original smoking status variables 
The whole reason for collecting smoking information was to enable the researchers to 
adjust their models for smoking, which is known to be a risk factor for lung cancer, which also 
happens to be one of the outcomes of interest.  The methods the authors used to gather and 
assign smoking histories to employees in the sub-cohort must be explored.  Information on an 
employee’s smoking history was obtained from one of three sources:  medical records, 
interviews with the actual employees, or interviews with an employee’s next-of-kin.  The 
cigarette smoking information gathered in the interviews included age started smoking, ever- or 
never-smoker, number of years smoked, amount smoked, and cigar or other tobacco use.  The 
results for each employee were coded and stored in the smoking analysis dataset (SMK_NCI).  
The smoking status of interest here is the binary smoking variable, ever- or never-smoker.  Four 
variables, QSMOKER, MSMOKER, SMKSTAT, and SMKSTAT2 are used to indicate ever- or 
never-smoker.  QMSMOKER and MSMOKER are not directly labeled in the SMK_NCI dataset, 
but appear to indicate an employee’s smoking status based on employee interview (QSMOKER) 
or employee medical records (MSMOKER).  These variables were coded as follows: 
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0 – never-smoker 
1 – ever-smoker 
8,9 – missing smoking information 
 
Table 6 shows the frequency distribution of the QSMOKER and MSMOKER variables for the 
entire sub-cohort. 
Table 6: Frequency distribution of NCI smoking status variables 
 
Cumul. Cumul.
variable description code description Freq. Freq. %
0 never 697 697 26.3%
1 ever 1193 1890 71.2%
8 unknown 765 2655 100.0%
0 never 384 384 14.5%
1 ever 651 1035 39.0%
8 1126 2161 81.4%
9 494 2655 100.0%unknown
smoking status from 
interview
smoking status from 
medical recordsMSMOKER
QSMOKER
 
 
 
 
3.2.2. Agreement between smoking status variables 
The authors reported that 1890 (71%) of the 2655 individuals in the sub-cohort 
completed an interview.  This is verified in the last column of the QSMOKER variable, where 
71.2% of the 2655 sub-cohort employees were either coded as a never- or ever-smoker.  
Similarly, the NCI paper reported the smoking information based on medical records was 
available for 1035 employees, which can be seen as the cumulative percent for MSMOKER 
equal to 0 or 1 (39.0%).  A value of 8 or 9 for an individual indicates an unknown smoking status 
based on either the questionnaire or medical records.  With either variable, the percentage of 
available smoking information is still rather low (39.0% for medical records and 71.2% for 
interviews). 
In order to maximize the available information, the authors created two additional 
variables, SMKSTAT and SMKSTAT2, which combine the medical records and interviews to 
determine if an employee was or was not a smoker.   
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But before doing this, the QSMOKER and MSMOKER results were compared to 
determine how closely the medical records and interviews agreed.  The NCI paper reports an 
agreement of 86% between the medical records and interviews using only those 1035 employees 
with available medical records.  Table 7 compares the MSMOKER and QSMOKER values. 
 
Table 7: Cross tabulation of QSMOKER and MSMOKER variables 
 
never ever unk
0 1 9 tota
never 0 248 69 67 384
ever 1 42 463 146 651
unk 9 407 661 552 1620
total 697 1194 774 2665
MSMOKER
QSMOKER
l
 
 
 
The reported agreement is calculated using only the concordant and discordant pairs for those 
individuals with a known smoking status from both sources.  The agreement is calculated as 
(248+463)/(248+69+42+463) = 711/822 = 86.5%.  When looking at the discordant pairs, it can 
be seen that there are 69 employees who were coded as never-smoker in their medical records 
but were coded as ever-smoker in their questionnaires.  There were 42 employees coded as ever-
smoker in the medical records but who were coded as never-smoker from the questionnaire.   
This result can be verified in Stata (StataCorp. 2005), which also produces the kappa 
statistic, which is a measure of agreement often used when comparing results from two or more 
raters.  The Stata output below shows the results: 
 
           |        QSMOKER 
   MSMOKER |     never       ever |     Total 
-----------+----------------------+---------- 
     never |       248         69 |       317  
      ever |        42        463 |       505  
-----------+----------------------+---------- 
     Total |       290        532 |       822  
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             Expected 
Agreement   Agreement     Kappa   Std. Err.         Z      Prob>Z 
----------------------------------------------------------------- 
  86.50%      53.37%     0.7104     0.0348      20.42      0.0000 
 
The kappa statistic equals 0.71, indicating a strong agreement between the medical record and 
interview smoking information (Rosner 2000).  The ‘agreement’ in the output equals the 86.5% 
calculated earlier.  But if the entire 3x3 table as shown above was analyzed in STATA, the 
results are quite different.   
 
 
           |             QSMOKER 
   MSMOKER |     never       ever    unknown |     Total 
-----------+---------------------------------+---------- 
     never |       248         69         67 |       384  
      ever |        42        463        146 |       651  
   unknown |       407        661        552 |     1,620  
-----------+---------------------------------+---------- 
     Total |       697      1,193        765 |     2,655  
 
             Expected 
Agreement   Agreement     Kappa   Std. Err.         Z      Prob>Z 
----------------------------------------------------------------- 
  47.57%      32.40%     0.2245     0.0121      18.48      0.0000 
 
 
In this case the agreement is only 47.6% with a kappa statistic of 0.225.  The difference is largely 
due to the number of individuals with missing smoking information from their medical records 
but who had smoking information available from the interviews. 
 
3.2.3. Smoking status variables created by NCI 
Based on the 86.5% agreement between the two smoking history sources, Blair created 
the two additional smoking variables, SMKSTAT and SMKSTAT2 to maximize this smoking 
information.  The SMKSTAT variable is a combination of smoking information based on both 
the interviews and medical records.  SMKSTAT2 is the same as QSMOKER, but with all of the 
unknown values recoded to 9.  The logic used by Blair to assign employees as ever- or never-
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smokers was to use the interview (questionnaire) when the smoking history was known (0 – 
never, 1 – ever), but to use the medical records if the interview smoking history was unknown (9 
– unknown).  A summary of the ever- never-smoker variables is shown in Table 8. 
Table 8: Description of ever-, never-smoker smoking status variables 
 
 
variable smoking information based on: levels description
QSMOKER interview (questionnaire) 0 never
1 ever
8 unknown
MSMOKER medical records 0 never
1 ever
8
9
variable smoking information based on: levels description
SMKSTAT interview (questionnaire) and medical records 0 never
use interview if not unknown, then medical records 1 ever
if available 9 unknown
SMKSTAT2 interview (questionnaire) 0 never
same as QSMOKE but unknowns recoded 1 ever
9 unknown
unknown
Original smoking history variables
Additional variables created in NCI analysis
 
 
The main ever-, never-smoker variable used in this paper for smoking descriptives and 
the NCI study is the SMKSTAT variable.  This was the variable created in the NCI analysis that 
maximized an employees smoking history by looking at both their medical records and the 
employee (or family) interviews.  The cross classification in Table 9 demonstrates the logic used 
for the creation of the ever-, never-smoker variable used in the NCI paper. 
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Table 9: NCI assignment of a smoking status (SMKSTAT) based on QSMOKER and MSMOKER variables 
 
QSMOKER MSMOKER 0 1 9
0 248 - - 248
1 42 - -
8 268 - - 268
9 139 - - 139
0 - 69 - 69
1 - 463 - 463
8 - 455 - 455
9 - 206 - 206
0 67 - -
1 - 146 - 146
8 - - 403 403
9 - - 149 149
Total 764 1339 552 2655
8
Total
SMKSTAT (interviews and medical records)
0
1
42
67
 
 
 
The table shows that there are 552 (403 + 149) employees where the ever-, never-smoker 
information is missing from both interviews and medical records.  There are two occurrences 
when the QMSMOKER variable disagreed with MSMOKER.  In both instances the interview 
information was assumed to be correct and took precedence over the medical information.  The 
SMKSTAT variable recoded 42 employees as never-smoker who were ever-smoker in their 
medical records, and recoded 69 employees as ever-smokers who were noted as never-smokers 
in their records.  Of the 765 employees who did not have smoking information from interviews 
(QSMOKER = 8), 213 (67 + 146) did have information available in the medical records. 
 
3.2.4. Analysis of discordant smoking status variables 
Because the authors assumed that the questionnaire information was correct in the 111 
individuals whose medical records disagreed with their questionnaires, it is important to check 
the distribution of these employees by AN exposure and lung cancer status.  Table 10 shows how 
the 111 discordant employees are distributed. 
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Table 10: Distribution of sub-cohort employees with discordant smoking histories by AN exposure 
 
 
unexposed 1 2 3 4 5 total
control 22 11 9 7 9 10 68
case 0 0 1 0 0 0 1
control 6 12 10 4 8 1 41
case 0 0 0 0 0 1 1
total 28 23 20 11 17 12 111
Cumulative AN exposure group
assigned as 
ever-smoker
assigned as 
never-smoker
NCI disposition lung cancer status
 
 
 
Only 2 lung cancer cases were among those employees with discrepancies between their 
medical record and questionnaire smoking statuses.  One of these was in the 2nd quintile of AN 
exposure and was assigned as an ever-smoker based on the questionnaire.  The other, and more 
important case, occurred in the upper quintile of AN exposure.  This employee was assigned as a 
never-smoker by the authors based on the questionnaire, although his smoking history in the 
medical records indicated ever-smoker.  As will be shown later, there are only 11 lung cancer 
cases in the upper quintile of AN exposure with known smoking histories, 8 ever- and 3 never-
smokers.  Because the three never-smoking cases include this one case described above and the 
never-smoking cases account for 27% of the total cases in the upper quintile, this reassignment 
by the study authors likely has an important impact on the reported lung cancer RR for the upper 
quintile of AN exposure after adjustment for smoking. 
 
3.3. Smoking Information for Sub-Cohort 
 
3.3.1. Demographic information 
Using the same ever- and never-smoking status variable as the study authors, SMKSTAT, 
the 552 employees with missing smoking information can be analyzed to see how the missing 
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vary among the lung cancer cases, the exposed workers, and other demographic variables to 
determine if there is a pattern in those with missing histories.  This also allows for comparison of 
the NCI study results to this reanalysis.  Table 11 shows the distribution of these employees with 
missing smoking information by race, gender, year of birth, and cumulative AN exposure group. 
 
Table 11: Frequency distribution of sub-cohort employees with missing smoking information by demographic 
and exposure variables 
 
 
Demographic Variable
Race
White 30 (90.9) 22 (78.6) 37 (86.0) 54 (79.4) 140 (89.2) 53 (86.9) 22 (81.5) 115 (85.2) 473 (85.7)
Nonwhite 3 (09.1) 5 (17.9) 4 (09.3) 14 (20.6) 17 (10.8) 8 (13.1) 5 (18.5) 20 (14.8) 76 (13.8)
Unknown 0 (00.0) 1 (03.6) 2 (04.7) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 3 (00.5)
Gender
Male 28 (84.8) 16 (57.1) 25 (58.1) 46 (67.6) 120 (76.4) 49 (80.3) 27 (100.0) 111 (82.2) 422 (76.4)
Female 5 (15.2) 12 (42.9) 18 (41.9) 22 (32.4) 37 (23.6) 12 (19.7) 0 (00.0) 24 (17.8) 130 (23.6)
Year of Birth
<1925 4 (12.1) 2 (07.1) 11 (25.6) 8 (11.8) 24 (15.3) 19 (31.1) 5 (18.5) 67 (49.6) 140 (25.4)
1925-1934 9 (27.3) 4 (14.3) 8 (18.6) 18 (26.5) 41 (26.1) 22 (36.1) 4 (14.8) 35 (25.9) 141 (25.5)
1935-1944 12 (36.4) 12 (42.9) 9 (20.9) 15 (22.1) 48 (30.6) 7 (11.5) 10 (37.0) 18 (13.3) 131 (23.7)
1945-1954 8 (24.2) 7 (25.0) 11 (25.6) 24 (35.3) 38 (24.2) 2 (03.3) 8 (29.6) 10 (07.4) 108 (19.6)
>1955 0 (00.0) 3 (10.7) 4 (09.3) 3 (04.4) 6 (03.8) 11 (18.0) 0 (00.0) 5 (03.7) 32 (05.8)
Unknown 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0) 0 (00.0)
AN exposure
Unexposed 8 (24.2) 19 (67.9) 34 (79.1) 15 (22.1) 66 (42.0) 25 (41.0) 7 (25.9) 62 (45.9) 236 (42.8)
Exposed 25 (75.8) 9 (32.1) 9 (20.9) 53 (77.9) 91 (58.0) 36 (59.0) 20 (74.1) 73 (54.1) 316 (57.2)
<0.13 ppm-yrs 11 (44.0) 5 (55.6) 1 (11.1) 33 (62.3) 33 (36.3) 19 (52.8) 7 (35.0) 31 (42.5) 140 (44.3)
0.13 to 0.57 ppm-yrs 5 (20.0) 1 (11.1) 0 (00.0) 5 (09.4) 16 (17.6) 8 (22.2) 8 (40.0) 12 (16.4) 55 (17.4)
0.57 to 1.5 ppm-yrs 5 (20.0) 2 (22.2) 0 (00.0) 4 (07.5) 11 (12.1) 7 (19.4) 0 (00.0) 16 (21.9) 45 (14.2)
1.5 to 8.0 ppm-yrs 3 (12.0) 1 (11.1) 2 (22.2) 5 (09.4) 16 (17.6) 2 (05.6) 5 (25.0) 12 (16.4) 46 (14.6)
>8.0 ppm-yrs 1 (04.0) 0 (00.0) 6 (66.7) 6 (11.3) 15 (16.5) 0 (00.0) 0 (00.0) 2 (02.7) 30 (09.5)
Total 33 (06.0) 28 (05.1) 43 (07.8) 68 (12.3) 157 (28.4) 61 (11.1) 27 (04.9) 135 (24.5) 552 (100.0)
Plant 1 Plant 2 Plant 3 Plant 4 Plant 5 Plant 6 Plant 7 Plant 8 Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
 
 
 
Plants 5 and 8 account for 28.4% and 24.5% of the missing values, respectively.  Plant 5 is the 
largest in the study and Plant 8 was the plant that had a large proportion of the cases.  Almost 
75% of the missing values occur for employees born prior to 1944 and 57% of the smoking 
histories are missing for employees ever-exposed to AN. 
The NCI paper reported that employees who ever-smoked cigarettes made up 66% of the 
sample.  A frequency tabulation of the SMKSTAT for the entire sub-cohort of employees (with 
available smoking information) results are shown in Table 12. 
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Table 12: Prevalence of smoking for sub-cohort employees 
 
 
     smoker |      Freq.     Percent        Cum. 
------------+----------------------------------- 
      never |        764       36.33       36.33 
       ever |      1,339       63.67      100.00 
------------+----------------------------------- 
      Total |      2,103      100.00 
 
 
The ever-smokers make up 1339 (64%) of the 2103 employees with a known smoking history.  
This is not exactly the same value reported in the original paper, but the 66% reported may only 
have included the employees in the 10% sample and not the entire sub-cohort as shown. 
 
3.3.2. Smoking and AN exposure 
The authors next looked at smoking status by exposure.  For employees categorized as 
ever- or never-exposed to acrylonitrile (AN), NCI reported 56% ever-smokers among the never-
exposed workers, while the prevalence of ever-smokers among the ever-exposed was 68%.  
Table 13 shows a cross-tabulation of the ever-, never-exposed to AN (ANSTATUS) against the 
smoking status variable, SMKSTAT. 
Table 13: Prevalence of smoking by AN exposure status 
 
           |      AN Exposure 
    smoker |     never       ever |     Total 
-----------+----------------------+---------- 
     never |       284        480 |       764  
   (row %) |     37.17      62.83 |    100.00  
(column %) |     43.69      33.04 |     36.33  
-----------+----------------------+---------- 
      ever |       366        973 |     1,339  
   (row %) |     27.33      72.67 |    100.00  
(column %) |     56.31      66.96 |     63.67  
-----------+----------------------+---------- 
     Total |       650      1,453 |     2,103  
   (row %) |     30.91      69.09 |    100.00  
(column %) |    100.00     100.00 |    100.00 
 
 
From Table 13, 56% of those never-exposed to AN were ever-smokers and 67% of those ever-
exposed were ever-smokers.  The results are close to those in the NCI study.  In Table 14, the 
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AN status in the 552 employees with missing smoking information shows that 57% of those 
were ever-exposed to AN.   
 
Table 14: Distribution of employees with missing smoking information by AN exposure status 
 
AN Exposure |      Freq.     Percent        Cum. 
------------+----------------------------------- 
      never |        236       42.75       42.75 
       ever |        316       57.25      100.00 
------------+----------------------------------- 
      Total |        552      100.00 
 
 
Smoking information can also be tabulated by quintile of cumulative AN exposure, as in Table 
15.  For the 1453 employees with complete smoking information and ever-exposed to AN, the 
ever-smokers made up 63%, 63%, 68%, 72%, and 74% of the employees in the exposure 
quintiles, 1, 2, 3, 4, and 5, respectively.  The smoking prevalence increases as the cumulative 
exposure increases. 
 
 
Table 15: Smoking history by quintile of AN exposure for employees with known smoking history 
 
           |                Quintile of AN Exposure 
    smoker |         1          2          3          4          5 |     Total 
-----------+-------------------------------------------------------+---------- 
     never |       191        100         66         75         48 |       480  
   (row %) |     39.79      20.83      13.75      15.63      10.00 |    100.00  
(column %) |     37.09      36.63      31.73      27.78      25.67 |     33.04  
-----------+-------------------------------------------------------+---------- 
      ever |       324        173        142        195        139 |       973  
   (row %) |     33.30      17.78      14.59      20.04      14.29 |    100.00  
(column %) |     62.91      63.37      68.27      72.22      74.33 |     66.96  
-----------+-------------------------------------------------------+---------- 
     Total |       515        273        208        270        187 |     1,453  
   (row %) |     35.44      18.79      14.32      18.58      12.87 |    100.00  
(column %) |    100.00     100.00     100.00     100.00     100.00 |    100.00 
 
 
With the addition of the exposed employees with missing smoking information, it can be seen in 
Table 16 that of the 316 employees missing smoking information, 44% were in quintile 1, 17% 
in quintile 2, 14% from quintile 3, 15% from quintile 4, and 14% from the upper quintile of AN 
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exposure.  Similarly, the proportion of missing smoking histories by cumulative AN exposure 
quintile is 0.21, 0.17, 0.18, 0.15, and 0.14 for quintiles one through five.   
 
Table 16: Smoking history by quintile of AN exposure for all employees in sub-cohort 
 
 
           |                Quintile of AN Exposure 
    smoker |         1          2          3          4          5 |     Total 
-----------+-------------------------------------------------------+---------- 
     never |       191        100         66         75         48 |       480  
   (row %) |     39.79      20.83      13.75      15.63      10.00 |    100.00  
(column %) |     29.16      30.49      26.09      23.73      22.12 |     27.13  
-----------+-------------------------------------------------------+---------- 
      ever |       324        173        142        195        139 |       973  
   (row %) |     33.30      17.78      14.59      20.04      14.29 |    100.00  
(column %) |     49.47      52.74      56.13      61.71      64.06 |     55.00  
-----------+-------------------------------------------------------+---------- 
   missing |       140         55         45         46         30 |       316  
   (row %) |     44.30      17.41      14.24      14.56       9.49 |    100.00  
(column %) |     21.37      16.77      17.79      14.56      13.82 |     17.86  
-----------+-------------------------------------------------------+---------- 
     Total |       655        328        253        316        217 |     1,769  
   (row %) |     37.03      18.54      14.30      17.86      12.27 |    100.00  
(column %) |    100.00     100.00     100.00     100.00     100.00 |    100.00 
 
 
 
3.3.3. Smoking and lung cancer status 
It is also important to analyze the missing smoking history pattern in the lung cancer 
cases and controls.  Table 17 shows the distribution of smoking status for the cases and controls.   
 
Table 17: Smoking history of cases and controls 
 
 
      lung |              smoker 
    cancer |     never       ever    missing |     Total 
-----------+---------------------------------+---------- 
   control |       757      1,282        423 |     2,462  
   (row %) |     30.75      52.07      17.18 |    100.00  
(column %) |     99.08      95.74      76.63 |     92.73  
-----------+---------------------------------+---------- 
      case |         7         57        129 |       193  
   (row %) |      3.63      29.53      66.84 |    100.00  
(column %) |      0.92       4.26      23.37 |      7.27  
-----------+---------------------------------+---------- 
     Total |       764      1,339        552 |     2,655  
   (row %) |     28.78      50.43      20.79 |    100.00  
(column %) |    100.00     100.00     100.00 |    100.00 
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From Table 17, only 17% (423/2462) of the controls are missing a smoking status, but 
approximately 67% (129/193) of the cases are missing the ever-, never-smoker value.  Of the 
552 missings, 423 (77%) are controls and 129 (23%) are lung cancer cases.   
Table 18: Smoking history of cases and controls, complete smoking histories only 
 
      lung |        smoker 
    cancer |     never       ever |     Total 
-----------+----------------------+---------- 
   control |       757      1,282 |     2,039  
   (row %) |     37.13      62.87 |    100.00  
(column %) |     99.08      95.74 |     96.96  
-----------+----------------------+---------- 
      case |         7         57 |        64  
   (row %) |     10.94      89.06 |    100.00  
(column %) |      0.92       4.26 |      3.04  
-----------+----------------------+---------- 
     Total |       764      1,339 |     2,103  
   (row %) |     36.33      63.67 |    100.00  
(column %) |    100.00     100.00 |    100.00 
 
 
 
Table 18 summarizes the cases and controls by smoking exposure for the non-missings 
only.  Of the controls, 63% were ever-smokers, while the smoking prevalence in the lung cancer 
cases was 89%.  Smoking causes about 90% of lung cancer deaths in men and about 80% in 
women, so the prevalence in this cohort, where 57 of the 64 cases were ever-smokers, appears to 
be in agreement with the general population. 
The missing smoking information can also be analyzed for the 193 lung cancer cases by 
AN exposure status as in Table 19.  The percentage of missing smoking information is 64% in 
the unexposed cases and 68% in the exposed cases.  
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Table 19: Smoking history by AN exposure status - lung cancer cases 
 
 
           |      AN Exposure 
    smoker |     never       ever |     Total 
-----------+----------------------+---------- 
     never |         3          4 |         7  
   (row %) |     42.86      57.14 |    100.00  
(column %) |      5.08       2.99 |      3.63  
-----------+----------------------+---------- 
      ever |        18         39 |        57  
   (row %) |     31.58      68.42 |    100.00  
(column %) |     30.51      29.10 |     29.53  
-----------+----------------------+---------- 
   missing |        38         91 |       129  
   (row %) |     29.46      70.54 |    100.00  
(column %) |     64.41      67.91 |     66.84  
-----------+----------------------+---------- 
     Total |        59        134 |       193  
   (row %) |     30.57      69.43 |    100.00  
(column %) |    100.00     100.00 |    100.00 
 
Table 20 shows the cases by cumulative AN exposure group.  For quintiles 1 through 5, 
the missing percentages are 86%, 68%, 70%, 57%, and 58% respectively.  The table also shows 
that are no never-smoking cases in exposure quintiles 1, 2, and 3 and only 1 and 3 never-
smoking cases in quintiles 4 and 5.  The ever-smoking cases are distributed relatively evenly 
across the exposure quintiles (4, 8, 8, 11, and 8), but over 30% (18/57) of the ever-smoking cases 
were never-exposed to AN.  
Table 20: Smoking history by AN exposure group - lung cancer cases 
 
 
           |                      Quintile of AN Exposure 
    smoker | unexposed          1          2          3          4          5 |     Total 
-----------+------------------------------------------------------------------+---------- 
     never |         3          0          0          0          1          3 |         7  
(column %)|      5.08       0.00       0.00       0.00       3.57      11.54 |      3.63  
-----------+------------------------------------------------------------------+---------- 
      ever |        18          4          8          8         11          8 |        57  
(column %)|     30.51      14.29      32.00      29.63      39.29      30.77 |     29.53  
-----------+------------------------------------------------------------------+---------- 
   missing |        38         24         17         19         16         15 |       129  
(column %)|     64.41      85.71      68.00      70.37      57.14      57.69 |     66.84  
-----------+------------------------------------------------------------------+---------- 
     Total |        59         28         25         27         28         26 |       193  
(column %)|    100.00     100.00     100.00     100.00     100.00     100.00 |    100.00 
 
 
The missingness of the smoking status variable for ever- or never-smoker can also be tabulated 
by other covariates in the original NCI dataset such as: plant, race, and gender. 
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3.3.4. Smoking status by plant  
For all employees in the sub-cohort and all 8 plants in the study, the percentage of 
employees with a missing smoking status ranges from a maximum of 28% in plant 8 to 12% in 
plant 7, as shown in Table 21.  The prevalence of ever-smokers ranges from a minimum of 50% 
(89/179) in plant 2 to a maximum of 73% (164/224) in plant 4. 
 
Table 21: Smoking history by plant for entire sub-cohort 
 
 
smoker 1 2 3 4 5 6 7 8 total
never 55 89 57 60 207 88 75 133 764
(row %) 7.2% 11.6% 7.5% 7.9% 27.1% 11.5% 9.8% 17.4% 100.0%
(column %) 27.9% 43.0% 32.0% 20.5% 26.6% 29.2% 33.3% 27.8% 28.8%
ever 109 90 78 164 413 152 123 210 1339
(row %) 8.1% 6.7% 5.8% 12.2% 30.8% 11.4% 9.2% 15.7% 100.0%
(column %) 55.3% 43.5% 43.8% 56.2% 53.2% 50.5% 54.7% 43.9% 50.4%
missing 33 28 43 68 157 61 27 135 552
(row %) 6.0% 5.1% 7.8% 12.3% 28.4% 11.1% 4.9% 24.5% 100.0%
(column %) 16.8% 13.5% 24.2% 23.3% 20.2% 20.3% 12.0% 28.2% 20.8%
total 197 207 178 292 777 301 225 478 2655
(row %) 7.4% 7.8% 6.7% 11.0% 29.3% 11.3% 8.5% 18.0% 100.0%
(column %) 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
plant
 
 
 
For only the 193 lung cancer cases by plant and smoking status, the missing rate is 
relatively constant across plants, ranging from 62% in plant 5 to 72% in plant 6 (Table 22).  The 
distribution of the 129 cases with missing smoking information is not so even across the eight 
plants.  Plant 2 accounts for only 3.1% of the employees with missing smoking information, 
while plant 8 accounts for 33.3% of these 129 lung cancer cases. 
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Table 22: Smoking history by plant for lung cancer cases 
 
smoker 1 2 3 4 5 6 7 8 Total
never 0 0 1 0 1 2 1 2 7
(row %) 0.0% 0.0% 14.3% 0.0% 14.3% 28.6% 14.3% 28.6% 100.0%
(column %) 0.0% 0.0% 9.1% 0.0% 2.6% 6.9% 10.0% 3.1% 3.6%
ever 3 2 3 8 14 6 2 19 57
(row %) 5.3% 3.5% 5.3% 14.0% 24.6% 10.5% 3.5% 33.3% 100.0%
(column %) 33.3% 33.3% 27.3% 32.0% 35.9% 20.7% 20.0% 29.7% 29.5%
missing 6 4 7 17 24 21 7 43 129
(row %) 4.7% 3.1% 5.4% 13.2% 18.6% 16.3% 5.4% 33.3% 100.0%
(column %) 66.7% 66.7% 63.6% 68.0% 61.5% 72.4% 70.0% 67.2% 66.8%
total 9 6 11 25 39 29 10 64 193
(row %) 4.7% 3.1% 5.7% 13.0% 20.2% 15.0% 5.2% 33.2% 100.0%
(column %) 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
plant
 
 
 
 
3.3.5. Smoking by race and gender 
The ever-, never-, and missing smoking information by race and gender are shown in 
Tables 23 and 24.  85% of the 552 missing smoking values are white and 14% are nonwhite.  
The ever-smoking prevalence is 65% (1196/1853) in whites and 57% (139/245) for nonwhites.   
 
 
Table 23: Smoking history by race for entire sub-cohort 
 
           |               race 
    smoker |     white   nonwhite      other |     Total 
-----------+---------------------------------+---------- 
     never |       657        106          1 |       764  
   (row %) |     85.99      13.87       0.13 |    100.00  
(column %) |     28.25      33.02      12.50 |     28.78  
-----------+---------------------------------+---------- 
      ever |     1,196        139          4 |     1,339  
   (row %) |     89.32      10.38       0.30 |    100.00  
(column %) |     51.42      43.30      50.00 |     50.43  
-----------+---------------------------------+---------- 
   missing |       473         76          3 |       552  
   (row %) |     85.69      13.77       0.54 |    100.00  
(column %) |     20.34      23.68      37.50 |     20.79  
-----------+---------------------------------+---------- 
     Total |     2,326        321          8 |     2,655  
   (row %) |     87.61      12.09       0.30 |    100.00  
(column %) |    100.00     100.00     100.00 |    100.00  
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Table 24: Smoking history by gender for entire sub-cohort 
 
 
           |        gender 
    smoker |      male     female |     Total 
-----------+----------------------+---------- 
     never |       572        192 |       764  
   (row %) |     74.87      25.13 |    100.00  
(column %) |     26.89      36.36 |     28.78  
-----------+----------------------+---------- 
      ever |     1,133        206 |     1,339  
   (row %) |     84.62      15.38 |    100.00  
(column %) |     53.27      39.02 |     50.43  
-----------+----------------------+---------- 
   missing |       422        130 |       552  
   (row %) |     76.45      23.55 |    100.00  
(column %) |     19.84      24.62 |     20.79  
-----------+----------------------+---------- 
     Total |     2,127        528 |     2,655  
   (row %) |     80.11      19.89 |    100.00  
(column %) |    100.00     100.00 |    100.00  
 
 
 
85% of the 552 missing smoking values are males and 15% are female.  The ever-smoking 
prevalence is 67% (1133/1705) in males and 52% (206/398) for females. 
 
3.3.6. Smoking and year of birth 
The year of birth of an employee is another variable that may have a relationship to an 
employees smoking status.  Four dummy variables were created for the five year of birth groups.  
The cutoff points for the year of birth groups were set at: <1925, 1925-1934, 1935-1944, 1945-
1954, and >=1955 to match the NCI study.  The baseline was the >= 1955 birth year group.  The 
percentages of missing smoking information for groups <1925, 1925-1934, 1935-1944, 1945-
1954, and >=1955 are 34%, 25%, 18%, 16%, and 13%, respectively (Table 25).  This decrease 
would be expected, as older employees may not have adequate records or would not be available 
for interview regarding his or her smoking history. 
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Table 25: Smoking history by year of birth for entire sub-cohort 
 
 
           |                     Year of Birth 
    smoker |     <1925  1925-1934  1935-1944  1945-1954     >=1955 |     Total 
-----------+-------------------------------------------------------+---------- 
     never |        68        115        213        249        119 |       764  
   (row %) |      8.90      15.05      27.88      32.59      15.58 |    100.00  
(column %) |     16.46      20.10      28.78      36.03      49.79 |     28.78  
-----------+-------------------------------------------------------+---------- 
      ever |       205        316        396        334         88 |     1,339  
   (row %) |     15.31      23.60      29.57      24.94       6.57 |    100.00  
(column %) |     49.64      55.24      53.51      48.34      36.82 |     50.43  
-----------+-------------------------------------------------------+---------- 
   missing |       140        141        131        108         32 |       552  
   (row %) |     25.36      25.54      23.73      19.57       5.80 |    100.00  
(column %) |     33.90      24.65      17.70      15.63      13.39 |     20.79  
-----------+-------------------------------------------------------+---------- 
     Total |       413        572        740        691        239 |     2,655  
   (row %) |     15.56      21.54      27.87      26.03       9.00 |    100.00  
(column %) |    100.00     100.00     100.00     100.00     100.00 |    100.00 
 
 
For only the 2103 employees with known smoking histories, the tabulation of the year of 
birth by never-, ever-smoker shows that the smoking prevalence decreases with the employee’s 
age is shown in Table 26.  The employees born before 1925 had a smoking prevalence of 75%, 
while the prevalence drops to 57% and 43% in the last two year of birth groups. 
 
 
Table 26: Smoking history by year of birth for sub-cohort employees with known smoking histories 
 
 
           |                     Year of Birth 
    smoker |     <1925  1925-1934  1935-1944  1945-1954     >=1955 |     Total 
-----------+-------------------------------------------------------+---------- 
     never |        68        115        213        249        119 |       764  
   (row %) |      8.90      15.05      27.88      32.59      15.58 |    100.00  
(column %) |     24.91      26.68      34.98      42.71      57.49 |     36.33  
-----------+-------------------------------------------------------+---------- 
      ever |       205        316        396        334         88 |     1,339  
   (row %) |     15.31      23.60      29.57      24.94       6.57 |    100.00  
(column %) |     75.09      73.32      65.02      57.29      42.51 |     63.67  
-----------+-------------------------------------------------------+---------- 
     Total |       273        431        609        583        207 |     2,103  
   (row %) |     12.98      20.49      28.96      27.72       9.84 |    100.00  
(column %) |    100.00     100.00     100.00     100.00     100.00 |    100.00 
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To summarize the smoking information, 20.8% (552/2655) of the 2655 employees in the 
smoking sub-cohort were missing a smoking status.  The percentage of missings in the lung 
cancer cases and controls varies greatly.  Smoking information is missing for 66.8% (129/193) of 
the cases, in contrast to a missingness rate of 17.2% (423/2462) in the controls. 
 
4. REANALYSIS 
4.1. Objectives 
 
In order to determine if the missing smoking information affected the results of the NCI 
paper, in particular the overall relative risk of lung cancer in ever- versus never-smokers and the 
smoking adjusted lung cancer relative risk of 1.6 in the upper quintile of AN exposure, a 
systematic method for assigning a smoking status to these unknowns is proposed.  Specifically, 
reassigning a smoking status (ever- or never-smoker) to the employees without a smoking 
history will be performed to achieve the following: 
• Increase the overall relative risk for lung cancer in ever- versus never-smokers from 3.6 
to 8.0-10.0 
• Increase the smoking status rate of response from 82.8% in the controls and 33.2% in the 
cases to 100% (all of the unknowns will be assigned as ever- or never-smokers) 
• Rerun the proportional hazards models to find the smoking adjusted lung cancer RR due 
to AN exposure in the upper quintile and compare to the NCI result 
 
One advantage of reassigning all of the unknowns as ever- or never-smokers is that all of the 
employees in the sub-cohort will be used in the proportional hazard regression model.  If the 
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model includes the SMKSTAT variable (ever- or never-smoker) used in the original NCI study 
and the sub-cohort is analyzed with this missing smoking history covariate, the risk set will only 
consist of 64 cases (strata).  On the other hand, if the remaining 129 lung cancer cases are 
assigned as ever- or never-smokers, all 193 lung cancer cases would be modeled, resulting in 193 
strata in the risk set. 
4.2. Reassignment of Smoking Status Variable 
 
4.2.1. Employees whose smoking histories did not agree 
This reassignment of unknown smoking histories will first focus on the employees whose 
smoking histories disagreed in the medical records and questionnaires.  Figure 3 is a flowchart 
describing this process.   
 
 
 
Figure 3: Reallocation flowchart 
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If the medical records and questionnaires were in agreement as to whether an employee was or 
was not a smoker, the smoking status will be assumed to be correct, known or unknown.  If there 
is disagreement in the medical records and questionnaire, three different reallocation schemes are 
proposed.  Reallocation #1 will assume that the questionnaire information is correct.  Therefore, 
the 111 discordant smoking histories will be assigned a smoking status based on the interviews.  
The other employees are assigned as ever- or never-smokers according to the available 
information (medical or interview).  This was the method used in the NCI study.  Reallocation #2 
assumes that the medical records are correct for these 111 individuals.  Reallocation #3 will 
reassign the 111 as unknown, assuming that the smoking histories are unknown because there is 
disagreement in the two smoking history sources.  Table 27 summarizes these reallocation 
schemes. 
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Table 27: Reallocation of smoking status for employees whose smoking status differs between the 
questionnaire and medical records 
 
 
never ever unknown
never 248 42 407
ever 69 463 661 →
unknown 67 146 552
never ever unknown never ever unknown
never 248 42 407 317 0 407
ever 69 463 661 → 0 505 661
unknown 67 146 552 67 146 552
never ever unknown never ever unknown
never 248 42 407 248 0 407
ever 69 463 661 → 0 463 661
unknown 67 146 552 67 146 663
medical records medical records
questionnaire 
(interview)
questionnaire 
(interview)
Reallocation #3 - Assume neither are correct, assign as unknown
original data reallocated data
original data reallocated data
medical records medical records
medical records
questionnaire 
(interview)
Reallocation #2 - Assume medical record smoking status is correct
111 employees remain in their original cells 
and are assigned based on questionnaire 
(NCI's method)
Reallocation #1 - Assume questionnaire smoking status is correct
original data
 
 
 
 
Reallocations #1 and #2 result in the same number of missings, 552, while reallocation #3 results 
in 663 unknowns.  Three new smoking status variables were created to replace the NCI’s ever-, 
never-smoking status indicator.  They are: q_smoke, m_smoke, and unk_smoke, and have been 
named to indicate the allocation of the 111 discordant observations.  Table 28 details this 
allocation. 
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Table 28: Frequency of smoking status for each of the 3 new reallocation schemes 
 
 
never 764 28.8
ever 1339 50.4
unknown 552 20.8
total 2655 100.0
never 791 29.8
ever 1312 49.4
unknown 552 20.8
total 2655 100.0
never 722 27.2
ever 1270 47.8
unknown 663 25.0
total 2655 100.0
b - this is the same as the NCI study variable 'smkstat' used to describe ever- or never-smoker
unk_smoke
smoking 
status
2 Assume medical record smoking status is correct m_smoke
description of reallocationa
a - reallocating only the 111 observations where the smoking status differs between the medical 
records and the questionnaires
Freq. %
Assume questionnaire smoking 
status is correct1 q_smoke
b
new smoking 
variableallocation
3 Assume both are unknown
 
 
 
 
The prevalence of smoking in reallocations #1 and #2 are similar, 50.4% and 49.4% respectively.  
Reallocation #3, which assumes both are unknown, has a smoking prevalence of 47.8%.  The 
percent of unknowns after allocation is 20.8% in schemes 1 and 2 but increases to 25% in 
scheme 3.  Once the three new variables have been created, there are still employees missing a 
smoking status. 
 
4.2.2. Reallocation of unknowns 
The question still remains as to how to assign a smoking history to the remaining 
employees with a missing smoking status.  If the lung cancer cases are stratified by cumulative 
AN exposure group and smoking status, crude odds ratios for smoking and lung cancer can be 
calculated within each AN exposure group, ignoring the unknowns.  If the goal is to raise the 
overall lung cancer risk due to smoking, the unknowns could be assigned in such a way as to 
maximize this odds ratio within each stratum.  If all of the unknown cases are assigned as ever-
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smokers and all of the unknown controls are assigned as never-smokers, the diagonal cells of 
each stratum would increase.  This would maximize the odds ratio within each stratum and for 
the total.  Conversely, if all of the unknown cases were assigned as never-smokers and all of the 
controls were assigned as ever-smokers, the crude odds ratio would be minimized.  The most 
logical, and believable, assignment of the unknowns would be to assign the unknown controls 
and cases in the same proportions as the known controls and cases.  Table 29 shows the crude 
odds ratios obtained for the original data, the minimum, the maximum, and the proportional 
allocation as described previously.   
 
Table 29: Crude odds ratios obtained for the original data, and the minimum, maximum, and proportional 
allocation schemes 
 
 
S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U
case 18 3 38 4 0 24 8 0 17 8 0 19 11 1 16 8 3 15 57 7 129
control 348 281 198 320 191 116 165 100 38 134 66 26 184 74 30 131 45 15 1282 757 423
case
control
case 18 41 - 4 24 - 8 17 - 8 19 - 11 17 - 8 18 - 57 136 -
control 546 281 - 436 191 - 203 100 - 160 66 - 214 74 - 146 45 - 1705 757 -
case
control
case 56 3 - 28 0 - 25 0 - 27 0 - 27 1 - 23 3 - 186 7 -
control 348 479 - 320 307 - 165 138 - 134 92 - 184 104 - 131 60 - 1282 1180 -
case
control
case 51 8 - 28 0 - 25 0 - 27 0 - 26 2 - 19 7 - 176 17 -
control 458 369 - 393 234 - 189 114 - 151 75 - 205 83 - 142 49 - 1538 924 -
case
control
S - ever-smoker
~S - never-smoker
U - smoking status unknown
- 5.26 0.94 6.22lung cancer OR 5.14 - -
91.2
55.4 62.7 62.4 66.8 71.2 74.3 62.5
24.46
P
ro
po
rti
on
al lung cancer
smoking prevalence  (%) 86.4 100.0 100.0 100.0 92.9 73.1
- - 15.26 3.51
88.5 96.4
42.1 51.0 54.5 59.3 63.9 68.6 52.1
100.0 100.0 100.0 96.4
M
ax
im
um
lung cancer
smoking prevalence  (%) 94.9
lung cancer OR 25.69 -
0.17 0.22 0.14 0.19lung cancer OR 0.23 0.07 0.23
29.5
66.0 69.5 67.0 70.8 74.3 76.4 69.3
4.81
M
in
im
um
lung cancer
smoking prevalence  (%) 30.5 14.3 32.0 29.6 39.3 30.8
- - 4.42 0.92
72.7 89.1
55.3 62.6 62.3 67.0 71.3 74.4 62.9
100.0 100.0 100.0 91.7
O
rig
in
al
 s
ub
-c
oh
or
t
lung cancer
smoking prevalence  (%)
85.7
lung cancer OR 4.84 -
AN cumulative exposure group Total
Unexposed 1 2 3 4 5
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The table uses the smoking status variable from the NCI paper, SMKSTAT.  The crude lung 
cancer odds ratio (OR) using the original data is 4.81 without stratifying by AN exposure group.  
The minimum and maximum attainable ORs are 0.19 and 24.5, respectively.  Even with this high 
OR of 24.5 overall for the maximum allocation, the OR in the uppermost AN exposure quintile is 
only 3.51.  This is due to the 3 non-smoking cases in this stratum.  The reallocation schemes #2 
and #3 shown in Table 28 will lower this cell count to 2 non-smoking cases, which should allow 
a greater increase within this stratum.  The proportionally allocated data yield similar results to 
the original, as expected, with slight differences due to rounding in the cells. 
Although these tables are crude odds ratios based on the stratum specific frequencies 
observed in the data and were not analyzed with the proportional hazards models, they do show, 
in the case of the maximum allocation, it should be possible to increase the overall lung cancer 
relative due to smoking from 3.6 to between 8.0 and 10.0.  It does also demonstrate that if the 
unknowns are simply allocated as ever- or never-smokers in the same proportion as the knowns, 
that the overall lung cancer RR would likely not be very different from the 3.6 in the original 
study. 
 
4.2.3. Logistic regression model to predict smoking status for unknowns 
Because the ever-, never- smoking status variable is binary (0 – never, 1 – ever), logistic 
regression can be used to determine which of the covariates are significant predictors of smoking 
status.  Demographic variables such as the employee’s year of birth, location of employment 
(plant), race, and gender will be included in the model.  Lung cancer, which is likely to be a 
significant predictor of ever-smokers, will also be included.  The baseline employee is a white 
male born in 1955 or later who worked in plant 8, does not have lung cancer, and was never 
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exposed to AN.  The results of the logistic regression on the 2103 complete records, with the 
event ‘ever-smoker’ as the dependent variable, are shown in Table 30. 
 
 
 
Table 30: Results of logistic regression to determine significant predictors of ever-smoker 
 
 
Logistic regression                               Number of obs   =       2103 
                                                  LR chi2(20)     =     162.20 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -1296.9712                       Pseudo R2       =     0.0588 
 
------------------------------------------------------------------------------ 
       smoke | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        lung |   3.124805    1.29707     2.74   0.006     1.385157     7.04931 
   yob_lt_25 |   3.849399   .8348264     6.22   0.000     2.516467    5.888363 
   yob_25_35 |   3.908099   .7468675     7.13   0.000     2.687166    5.683772 
   yob_35_45 |   2.604454   .4547217     5.48   0.000     1.849703    3.667172 
   yob_45_55 |   1.871962    .318869     3.68   0.000     1.340614    2.613908 
      ancum1 |   1.286419   .1789655     1.81   0.070     .9794089    1.689666 
      ancum2 |   1.149289   .1847574     0.87   0.387     .8386717     1.57495 
      ancum3 |   1.277242   .2328886     1.34   0.180     .8934441    1.825907 
      ancum4 |   1.414466   .2435062     2.01   0.044     1.009379    1.982122 
      ancum5 |   1.354296   .2732655     1.50   0.133     .9119287    2.011251 
      female |   .6406542    .082283    -3.47   0.001     .4980797    .8240404 
   nonwhite2 |   .8508262    .127886    -1.07   0.282     .6337216    1.142308 
   nonwhite3 |   3.245685   3.727275     1.03   0.305      .341826    30.81824 
      plant1 |   1.321757    .275449     1.34   0.181     .8785464     1.98856 
      plant2 |   .8864419   .1759991    -0.61   0.544     .6006867    1.308135 
      plant3 |   1.223061   .2712366     0.91   0.364      .791914    1.888939 
      plant4 |   2.501397   .5177097     4.43   0.000     1.667289     3.75279 
      plant5 |   1.453574   .2190033     2.48   0.013     1.081908    1.952916 
      plant6 |   1.399542   .2585697     1.82   0.069       .97437    2.010241 
      plant7 |   1.217748   .2399034     1.00   0.317     .8276861    1.791633 
 
 
 
From Table 30, lung cancer, year of birth, and gender (female) are significant predictors of 
smoking status.  Several of the plants and one of the AN exposure quintiles are also significant.  
Race is not.  The odds ratio for ever-smoker decreases in the age groups, which suggests that the 
older employees were more likely to be smokers than the younger employees.  This was also 
observed in the table of smoking status versus year of birth, which showed the same decrease in 
smoking prevalence as the employees got younger. 
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A logical next step would be to predict a smoking status for the 552 employees with 
missing smoking information based on this model.  Because all of these covariates are known for 
the 552 employees, the model could be used to predict whether or not a specific employee was a 
smoker or non-smoker based on lung cancer status, year of birth, AN cumulative exposure 
group, gender, plant, and race.  But using the predicted probabilities may not achieve the desired 
effect of increasing the overall lung cancer RR due to smoking. 
 
4.2.4. Proposed reallocation of unknowns 
Figure 4 summarizes the next proposed steps in the analysis.   
Sub-cohort with 3
new smoking
status variables
and unknowns
Reallocation #1
(NCI study)
Run analysis with
unknowns
(duplicate NCI results)
method
Weight cases and controls to
increase overall lung cancer RR
due to smoking
Single overall lung cancer RR for smoking
RR by quintile of AN exposure
Impute smoking history based on
sub-cohort covariates
Results
Reallocation #2 Reallocation #3
For each of the allocations above:
Overall lung cancer RR for smoking
combined over the imputations
RR by quintile of AN exposure combined
over the imputations
Overall lung cancer RR for smoking
combined over the imputations
RR by quintile of AN exposure combined
over the imputations
Run analysis on ‘complete’
imputed dataset
Run analysis on ‘complete’
imputed dataset
Unweighted Weighted
Results Results
Impute smoking status
for unknowns
 
 
 
Figure 4: Flowchart of required analyses for the 3 reallocations 
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The first step will be to run the analysis of the case-cohort data using the three newly created 
smoking status variables.  The q_smoke variable will reproduce the NCI study results.  The other 
variables, m_smoke and unk_smoke will also be modeled.  At this point, the analysis will 
include employees with an unknown smoking status, thus the goal of increasing the smoking 
status response rate to 100% will not be achieved.  These individuals will drop out of the analysis 
because the smoking information is missing.  The other approach will be to impute a smoking 
status for the unknowns and then analyze the sub-cohort as if the smoking status had been 
observed for all individuals.  The dataset would be complete, but the overall lung cancer relative 
risk may not increase from the 3.6 reported in the NCI study.  Therefore, 2 imputation schemes 
are proposed; an unweighted, which will use a method similar to the regression model discussed 
earlier and a weighted, which will apply more influence to certain individuals to force an 
increase to the overall lung cancer RR due to smoking.  Details of the imputation process are 
discussed in the next section.  The overall lung cancer RR due to smoking and the lung cancer 
RRs by AN cumulative exposure quintile will be obtained for each of the three allocation 
schemes using each of the three analyses: modeling with the unknowns, unweighted imputation, 
and weighted imputation. 
 
4.3. Imputations 
 
4.3.1. Description 
Imputation of missing data is an approach that involves filling-in the missing data and 
then analyzing this imputed dataset as if there were no missing data (Rubin 1976; Schafer 1999; 
Little and Rubin 2002).  In the NCI smoking sub-cohort, all of the employees with missing 
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smoking information were removed from any analysis using the smoking history covariate.  This 
is called case-deletion (Little and Rubin 2002).  If it can be assumed that the deleted observations 
are a representative sub-sample of the complete observations, then the case-deletion method may 
be reasonable.  But in the NCI data, the proportions of employees with missing smoking histories 
are much different in the cases and controls, so the deleted cases are not a representative sub-
sample of the complete data (the cases make up 23% (129/552) of the missing data but only 3% 
(64/2103) of the complete data). 
For the NCI smoking sub-cohort, imputation would involve filling-in a smoking status 
for the 552 employees whose status was missing, and then running the proportional hazard 
regression on this imputed dataset to obtain the parameter estimates.  The smoking status would 
be imputed using a model (e.g. logistic regression) of the complete case information with 
selected covariates (lung cancer status, gender, year of birth, etc.).   
Multiple imputation is an extension of imputation where the imputation procedure is 
repeated m times.  For each of the m independent imputations, an entire imputed dataset is 
created (Schafer 1999).  For the NCI data, if m = 5, there would be 5 newly created datasets, 
where the employees with a missing smoking status would have an imputed smoking status, sm1, 
sm2, sm3, sm4, and sm5. , where smi is the imputed smoking status for the ith imputation, i = 1, 2, 3, 
4, 5.  The smoking status imputed for each of the missings will be generated independently for 
each imputation, based on the results of the modeling.  The complete observations from the 
original data would be duplicated for each of the m datasets and would retain their original 
information.  Each of the m datasets are analyzed separately and the results are combined using 
the methods discussed by Little and Rubin (2002) to obtain final estimates.  For the estimates, 
the mean is used as the summary for the m imputations. 
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4.3.2. Unweighted imputation description 
Several procedures have been developed in Stata by Royston (Royston 2004; Royston 
2005a; Royston 2005b) to perform imputation of missing values.  One of the procedures, ice, is 
designed for multivariate imputation, where there may be missing values for more than one 
covariate as well as the dependent variable (Van Buuren and Oudshoorn 1999).  The other 
macro, uvis, is of interest here.  It is a univariate imputation procedure designed to impute 
missing values for a single dependent variable given fully observed covariates (independent 
variables).  The NCI data can be imputed using this program because only the smoking status 
(dependent variable) is missing and the covariates are fully observed (except for one employee in 
the controls whose year of birth was missing).  This univariate imputation procedure uses a 
regression command, such as logistic regression, to predict the value of the outcome (dependent 
variable) based on the covariates in the regression model.  For the NCI data, the outcome 
variable is smoking status, which is a binary outcome, so logistic regression is appropriate.  
Predicted values of the smoking status variable are calculated for those individuals with missing 
smoking information based on the regression of the complete data.  The univariate imputation 
algorithm defined by Van Buuren et al. (1999) and incorporated by Royston (2004; 2005a) in 
Stata is as follows: 
Assumptions: 
• Let  be observations where the outcome is fully observed and  indicates the 
observations where the outcome is missing 
obsY misY
• Missing values occur only in the outcome variable,  misY
• Dependent variables X are completely observed 
• Let  denote the predictors for the complete observations,  obsX obsY
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• Let  denote the predictors for the observations with a missing outcome,  misX misY
Steps: 
• Calculate and  ( ) ,ˆ,1 obsobsobsobs YXWXXW ′=′= − β βˆˆ obsobs XY =
• Bootstrap option: 
o Draw bootstrap sample of nonmissing observations 
o Regress the dependent variable  on  obsY obsX
o Estimate  *βˆ
• Calculate predicted values  *ˆˆ βmismis XY =
• For missing values  find the observation where is closest to  misni ,...,1= obsYˆ imisY ,ˆ
• Take  of that observation as the imputed value of  obsY .i
• Repeat steps m times to get ( ) ( ) ( )mmismismis YYY ,...,, 21 , the multiple imputations of the outcome 
variable 
 
4.3.3. Stata imputation procedures 
The uvis procedure in Stata follows this algorithm (with the bootstrap option) and follows 
the syntax below (Royston 2005a): 
uvis regression_cmd yvar xvarlist [if] [in] [weight], 
gen(newvarname)[boot seed(#)] 
    
 
The relevant options in  uvis are: 
• regression_cmd – type of regression used to impute the missing Y values (logistic, 
conditional logistic, etc.) 
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• yvar – dependent variable, Y, for which values will be imputed (non-missing values will 
not be imputed) 
• xvarlist – prediction covariates used in regression model 
• gen(newvarname) – imputed Y values can be stored under a user defined 
newvarname.  Contains the original (nonmissing) and imputed (originally missing) 
values of yvar. 
• boot – specifies bootstrap sampling be used to obtain the predicted parameter estimate 
 *βˆ
• seed(#) – enables user to set seed so imputations can be reproduced 
 
The logistic regression output showed which of the covariates in the dataset significantly 
predicted smoking status.  They were: lung cancer status, year of birth, gender, and one of the 
AN exposure quintiles.  These covariates will be used in the univariate imputations (Van Buuren 
et al. 1999).  Although some of the plants were significant, plant will not be used in the 
prediction equation because it is not one of the covariates used for adjustment in the proportional 
hazards models run in the original NCI study. 
 
4.3.4. Unweighted imputation for 3 allocations 
The unweighted imputations were run in Stata for each of the three reallocations discussed 
previously and were performed 100 times, creating 300 additional smoking status variables.  The 
uvis command was embedded in a do loop to iterate from 1 to 100 imputations. 
The Stata code used is as follows: 
Reallocation #1, using smoking status variable “q_smoke”: 
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. forvalues i = 1(1)100 { 
  2. uvis logistic q_smoke lung female ancum1 ancum2 ancum3 ancum4 ancum5  yob_lt_25 
yob_25_35 yob_35_45 yob_45_55, gen(imp_qv2_`i') boot seed(9432`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
552 missing observations on q_smoke imputed from 2103 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
The uvis procedure is called 100 times and will impute values of “q_smoke” based on 
the lung cancer, gender, AN exposure, and year of birth covariates.  The new variable 
“imp_qv2_i” will contain the imputed values of smoking status for the 552 missing observations 
and the 2103 existing smoking statuses.  The bootstrap option was specified and the seed was set 
at an initial value of 9432`i’ and will be incremented from i = 1 to 100.  The 2nd to last line from 
the output describes the process for the first imputation and states that “552 missing observations 
on q_smoke imputed from 2103 complete observations”.  This line is reproduced for each of the 
100 imputations (but is not shown to conserve space).  The other reallocations are similar except 
for the dependent variable and the names of the newly imputed smoking variables. 
 
Reallocation #2, using smoking status variable “m_smoke”: 
 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic  m_smoke lung female ancum1 ancum2 ancum3 ancum4 ancum5  yob_lt_25 
yob_25_35 yob_35_45 yob_45_55, gen(imp_mv2_`i') boot seed(49932`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
552 missing observations on m_smoke imputed from 2103 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
In this case, “m_smoke” is imputed using the same predictors. 
 
Reallocation #3, using smoking status variable “unk_smoke”: 
 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic  unk_smoke lung female ancum1 ancum2 ancum3 ancum4 ancum5  
yob_lt_25 yob_25_35 yob_35_45 yob_45_55, gen(imp_unkv2_`i') boot seed(3888`i') 
 47
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
663 missing observations on unk_smoke imputed from 1992 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
 
“unk_smoke” is imputed using the same predictors, but notice the difference in the 
number of imputed observations, 663.  This is because the 111 discordant smoking statuses were 
assumed to be unknown in Reallocation #3.   
The 100 new smoking status variables that were imputed for each of the 3 reallocation 
scenarios were then exported to text files along with the employee ID so these new variables 
could be matched to the employee in the SMK_NCI SAS dataset.  The proportional hazards 
regression models can then be run for each of the newly imputed smoking status variables to get 
the lung cancer RRs or other parameter estimates for each imputation.  These estimates would 
then be combined using Rubin’s method to obtain the final set of estimates.  And because there 
are no missing smoking status variables, all 2655 employees in the sub-cohort will be included in 
the analysis. 
But the same issue of the lung cancer relative risk still arises.  Because the complete 
observations are used to impute the missing values, the unknowns will be assigned as ever- or 
never-smokers in a similar manner as the complete observations, which alone yielded the overall 
RR of 3.6.  Analysis of the imputed datasets would likely result in similar RRs.  To overcome 
this, the smoking status for the unknown cases and controls will be imputed using separate 
regression models to force the lung cancer relative risk due to smoking into the 8.0 to 10.0 range. 
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4.3.5. Weighted imputation description 
From analysis of the 2x2 tables shown earlier, the relative risk can theoretically be 
maximized by coding the unknown lung cancer cases as ever-smokers and assigning the 
unknown controls as never-smokers.  This would be the most extreme assignment of the 
unknowns and would not be very believable, because the smoking prevalence in the complete 
information is not 100% in the lung cancer cases and 0% in the controls.  A method of weighting 
is proposed that will incorporate both the AN cumulative exposure group and the case/control 
status into the weighting.  Imputation will be carried out, but this time using a weighted logistic 
regression model as the prediction equation.   
The weighted regressions will again use the q_smoke, m_smoke, and unk_smoke 
smoking status variables created for each of the three reallocation plans.  Because the prevalence 
of smoking increases with the cumulative AN exposure and smoking is related to lung cancer, 
the cases in the upper quintile of AN exposure will be weighted so that an unknown case in that 
group is more likely to be imputed as an ever-smoker.  Likewise, the controls in the upper 
quintile will be weighted in such a way that the individual will be more likely reassigned as a 
never-smoker than an ever-smoker. 
Table 31 shows the proposed weighting scheme.  The ever-smoking cases are applied 
weights of 1, 2, 4, 6, 8, and 10 for cumulative AN exposure quintiles 0 (unexposed), 1, 2, 3, 4, 
and 5, respectively.  The never-smoking cases are assigned a weight of 1.  In the controls, the 
ever-smokers are unweighted.  The never-smoking controls are weighted in a similar manner as 
the ever-smoking cases, increasing in magnitude from 1 (unweighted) in the unexposed, to 10 in 
the upper quintile of AN exposure. The table shows the frequency of the complete observations 
within each of the AN exposure groups.  The case weighted imputations will be based on 64, 64, 
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and 62 complete lung cancer cases for the variables q_smoke, m_smoke, and unk_smoke, 
respectively.  The control weighted imputations will be based on 2039 complete observations for 
q_smoke and m_smoke, but only 1930 observations for unk_smoke. 
 
Table 31: Proposed weighting for cases and controls for the 3 reallocation schemes 
 
AN
exposure group weight obs. weight obs. weight obs. weight obs. weight obs. weight obs.
unexposed 1 18 1 3 1 18 1 3 1 18 1 3
1 2 4 1 0 2 4 1 0 2 4 1 0
2 4 8 1 0 4 7 1 1 4 7 1 0
3 6 8 1 0 6 8 1 0 6 8 1 0
4 8 11 1 1 8 11 1 1 8 11 1 1
5 10 8 1 3 10 9 1 2 10 8 1 2
57 7 57 7 56 6
AN
exposure group weight obs. weight obs. weight obs. weight obs. weight obs. weight obs.
unexposed 1 348 1 281 1 332 1 297 1 326 1 275
1 1 320 2 191 1 321 2 190 1 309 2 179
2 1 165 4 100 1 166 4 99 1 156 4 90
3 1 134 6 66 1 131 6 69 1 127 6 62
4 1 184 8 74 1 183 8 75 1 175 8 66
5 1 131 10 45 1 122 10 54 1 121 10 44
1282 757 1255 784 1214 716
never-smoker never-smoker never-smoker
Control Weighting Applied to Complete Observations
ever-smoker ever-smoker ever-smoker
ever-smokernever-smoker never-smokerever-smoker
q_smoke m_smoke
Case Weighting Applied to Complete Observations
never-smoker
unk_smoke
q_smoke m_smoke unk_smoke
ever-smoker
 
 
The type of weight used in the upcoming weighted imputations is called a frequency 
weight in Stata (StataCorp. 2005).  A simple example that demonstrates frequency weighting is 
shown in Table 32.  The 2x2 table on the left shows a hypothetical crude odds ratio calculation 
for lung cancer and cigarette smoking.  With no frequency weighting, the OR = 9.33.  If a 
frequency weight of 10 is applied only to the ever-smoking lung cancer cases, as shown in the 
2x2 table on the right, the odds ratio increases by a factor of 10 from 9.33 to 93.33.  The 
frequency weight of 10 treats each of the ever-smoking cases as 10 individuals, so the cell count 
is multiplied by the frequency weight. 
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Table 32: Example of frequency weighting 
 
 
never ever total never ever total
control 40 10 50 control 40 10 50
case 15 35 50 case 15 350* 365
total 55 45 100 total 55 360 415
OR = (40*35)/(15*10) = 9.33 OR = (40*350)/(15*10) = 93.33
* Frequency weighting treats each lung cancer ever-smoker as 10 individuals
No weighting Frequency weighting = 10
lung 
cancer
smoker smoker
lung 
cancer
 
 
 
If the frequency weight is added to the logistic regression prediction equation in the uvis 
procedure, the weighted observations will have more influence in predicting the smoking status 
of the unknowns.  The frequency weighting is not adding observations to the dataset, but merely 
adding more influence to certain covariate combinations, such as ever-smoking lung cancer 
cases, that are used in predicting a smoking status for the unknowns. 
 
4.3.6. Weighted imputation for 3 allocations 
Performing the weighted imputations requires a few more steps than the unweighted 
imputation shown earlier.  The basic steps are: 
o Create control and case weights for each of the variables q_smoke, m_smoke, and 
unk_smoke according to Table 31 
o Impute a smoking status for the q_smoke, m_smoke, or unk_smoke variables for the 
cases only, using the appropriate case weights 
o Impute a smoking status for the q_smoke, m_smoke, or unk_smoke variables for the 
controls only, using the appropriate  control weights 
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o Combine the case imputed and control imputed variables into a single smoking status 
variable for each of the three reallocations, q_smoke, m_smoke, and unk_smoke 
100 weighted imputations were run for each of the three reallocations.  The uvis command 
was embedded in a loop to iterate 1 to 100 imputations for the cases and then for the controls, 
using the appropriate weights.  The Stata code used is as follows: 
 
Reallocation #1, using smoking status variable “q_smoke”: 
 
 
Case imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic q_smoke lung  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= wt_case_q] if 
lung==1, gen(imp_q`i') boot seed(555`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
129 missing observations on q_smoke imputed from 64 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
Control imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic q_smoke cntr_ind  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= 
wt_ctrl_q] if cntr_ind==1, gen(imp_ctrl_q`i') boot seed(77789`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
423 missing observations on q_smoke imputed from 2039 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
 
 
For the case imputations, the logistic regression model is again used, but this time the 
only predictors in the model are lung cancer and the AN cumulative exposure quintiles.  The 
[fw= wt_case_q] option specifies the variable that contains the case frequency weight, in 
this example the case weights for q_smoke would be assigned.  The imputation is limited to the 
cases by the ‘if lung==1‘ command.  As in the unweighted imputations, the bootstrap was 
used. 
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The controls were imputed using AN cumulative exposure groups but without the lung 
cancer variable as was done with the controls.  The variable ‘cntr_ind’ was created and is just a 
binary indicator variable that equals 1 if the individual is a control and 0 if the individual is a 
case.  This variable was created so the cases and controls could be weighted and imputed 
separately.  
  
Reallocation #2, using smoking status variable “m_smoke”: 
 
 
Case imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic m_smoke lung  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= wt_case_m] if 
lung==1, gen(imp_m`i') boot seed(1212`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
129 missing observations on m_smoke imputed from 64 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
 
Control imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic m_smoke cntr_ind  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= 
wt_ctrl_m] if cntr_ind==1, gen(imp_ctrl_m`i') boot seed(8789`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
423 missing observations on m_smoke imputed from 2039 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
Reallocation #3, using smoking status variable “unk_smoke”: 
 
 
Case imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic  unk_smoke lung  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= 
wt_case_unk] if lung==1, gen(imp_unk`i') boot seed(678`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
131 missing observations on unk_smoke imputed from 62 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
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Control imputation 
 
. forvalues i = 1(1)100 { 
  2. uvis logistic  unk_smoke cntr_ind  ancum1 ancum2 ancum3 ancum4 ancum5 [fw= 
wt_ctrl_unk] if cntr_ind==1, gen(imp_ctrl_unk`i') boot seed(789`i') 
  3. } 
[imputing by drawing from conditional distribution with bootstrap] 
 
532 missing observations on unk_smoke imputed from 1930 complete observations. 
[imputing by drawing from conditional distribution with bootstrap] 
 
 
After combing the case imputations and the control imputations, the 100 new smoking 
status variables for each of the 3 reallocation scenarios were then exported to text files along 
with the employee ID so the new variables could be matched to the employee in the SMK_NCI 
SAS dataset. 
 
5. RESULTS 
5.1. Overall Lung Cancer RR Due to Smoking 
 
5.1.1. Analysis of 3 reallocations – including missing data 
The first goal of this analysis was to increase the overall relative risk for lung cancer due 
to smoking from the 3.6 reported in the NCI study to a range of 8.0 to 10.0.  The results of 
running the proportional hazards models for the sub-cohort (without any imputation of the 
missing values) are shown in Table 33 along with the NCI study result.  The dependent variable 
in the model is lung cancer with only one predictor, smoking status. 
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Table 33: Overall lung cancer RR due to smoking for the analyses without imputation of missing data 
 
 
assignment of lung cancer
design smoking status outcome predictor RR
NCI study questionnaire lung cancer smkstat 3.6
NCI study reanalysis questionnaire lung cancer smkstat 3.87
reallocation #1 questionnaire lung cancer q_smoke 3.87
reallocation #2 medical records lung cancer m_smoke 4.22
reallocation #3 unknown lung cancer unk_smoke 4.40  
 
 
The NCI lung cancer RR of 3.6 could not be reproduced exactly; the reanalysis resulted 
in a slightly higher RR of 3.87.  As should be expected, the lung cancer relative risks for the NCI 
study reanalysis with smkstat as the predictor and reallocation #1 with q_smoke as the predictor 
are identical.  This is because the smkstat and q_smoke variables are the same.  When the 111 
discordant medical record and questionnaire observations are reallocated in #2 and #3, the RRs 
increase to 4.22 and 4.40, respectively.  The increase is larger in reallocation #3, because those 
individuals with conflicting information were assumed to be unknown.  Among the 111, there 
were 2 cases who, in q_smoke, were assigned a smoking history, but with the unk_smoke 
variable, the two cases would not have been modeled and assumed to have missing smoking 
histories. 
 
5.1.2. Analysis of 3 reallocations – imputations 
The overall RR can now be analyzed for the imputed data.  Recall that for each of the 
three allocations, unweighted and weighted imputations were performed.  This results in 600 
new smoking status variables.  For each variable, the proportional hazards model was run using 
SAS software to obtain the overall lung cancer relative risk due to smoking.  For each of the six 
groups, the mean, median, percentiles, and other descriptive statistics can be calculated for the 
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100 relative risks obtained from the imputed datasets.  Figures 5 – 10 show the distributions of 
the overall lung cancer relative risks for each of the three allocation schemes and weighting.  The 
reference line in the box plots is the NCI study’s 3.6 RR, the dashed line is the median. 
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Figure 5: Distribution of 100 imputed RRs for unweighted and weighted q_smoke variable 
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Figure 6: Boxplots of 100 imputed RRs for unweighted and weighted q_smoke variable 
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Figure 7: Distribution of 100 imputed RRs for unweighted and weighted m_smoke variable 
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Figure 8: Boxplots of 100 imputed RRs for unweighted and weighted m_smoke variable 
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Figure 9: Distribution of 100 imputed RRs for unweighted and weighted unk_smoke variable 
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Figure 10: Boxplots of 100 imputed RRs for unweighted and weighted unk_smoke variable 
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Table 34 shows the descriptive statistics for the overall lung cancer RR for each of the 
allocation schemes and each of the imputation types (unweighted or weighted).  The relative 
risks in the weighted imputations are higher than those of the unweighted imputations for each of 
the allocation schemes.  This effect is most pronounced in reallocation 3, where the 111 
discordant smoking histories were assumed to be unknown.  The median RRs for the unweighted 
and weighted for unk_smoke are 4.41 and 5.62, respectively.  None of the medians are up to the 
desired 8.0-10.0 value, but with the weighted m_smoke and weighted unk_smoke smoking 
variable, the 75th percentile value for the RRs are 7.06 and 8.53, respectively.  This shows that in 
the weighted imputations for reallocations 2 and 3, an RR of 7.0-8.0 could occur with some 
regularity and not just happen due to chance alone. 
Table 34: Descriptive statistics for the 100 imputed RRs by each reallocation 
 
10 25 50 75 90
unweighted 4.17 2.04 12.07 2.50 3.10 3.93 4.76 5.95
weighted 5.29 1.86 16.84 2.71 3.35 4.45 6.44 9.11
unweighted 4.64 1.95 9.12 3.00 3.44 4.33 5.66 6.92
weighted 6.22 1.65 18.35 3.24 4.10 5.21 7.06 10.84
unweighted 4.88 2.09 13.29 3.07 3.52 4.41 5.48 7.28
weighted 6.37 2.01 21.29 2.80 3.52 5.62 8.53 10.26
percentilestype of 
imputation mean min max
3 unk_smoke
reallocation
imputed 
smoking 
variable
1 q_smoke
2 m_smoke
 
 
 
The medians of the unweighted imputations are very comparable to the RRs from Table 
33, which shows that the imputation of the smoking status based on the selected covariates yields 
similar results to the proportional hazard modeling of the complete observations.  From Table 33, 
the RRs for q_smoke, m_smoke and unk_smoke are 3.87, 4.22, and 4.40, respectively.  For the 
unweighted imputations in Table 34, the median RRs are 3.93, 4.33, and 4.41. 
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5.2. Lung Cancer RR in Upper Quintile of AN Exposure 
 
5.2.1. Average cell counts for imputed data by reallocation and weight 
The next part of the analysis is to rerun the proportional hazards models with the 
unweighted and weighted imputed values for each of the three reallocations schemes and see 
how the lung cancer RR due to AN exposure in the upper quintile is affected.  Tables 35 and 36 
show the average cell counts stratified by cumulative AN exposure group for the three 
allocations and each of the 100 unweighted and weighted imputations.  The original sub-cohort 
(based on the NCI smoking status variable) values are also shown.  Table 35 shows that the 
smoking prevalence increases by AN exposure quintile in a similar manner to the original data.  
The total crude odds ratios are also similar, only reaching a maximum of 5.59 for the unk_smoke 
allocation.  The RR in the upper quintile of AN exposures ranges from 1.75 with the q_smoke 
variable to 2.98 using m_smoke.  The assumption that the questionnaire information is correct 
never allows any of the imputed cell counts for the never-smoking cases to drop below the 
original sub-cohort value of 3, which prevents the RR in the upper stratum of AN exposure to 
increase significantly.  When the discordant histories are assumed unknown (unk_smoke), the 
average count in this cell drops to 3.0 resulting in an RR of 2.74 due to smoking in the upper 
quintile. 
The weighted imputation average cell counts are shown in Table 36.  The two most 
noticeable differences are the smoking prevalence in the controls across the exposure groups and 
the lung cancer RR due to smoking in the upper quintile of AN exposure.  In the m_smoke 
allocation, the smoking prevalence in the controls by exposure group is 53%, 60%, 59%, 61%, 
66% and 65% in contrast to the original sub-cohort’s 55%, 63%, 62%, 67%, 71%, and 74%.  
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This shows how the frequency weighting assigns more of the controls as never-smokers.  The 
lung cancer RRs due to smoking in the upper quintile of AN exposure have now increased to 
5.13 and 4.49 in the m_smoke and unk_smoke allocations, respectively.  However, the total RRs 
have not significantly increased for any of the allocations in the weighted imputations. 
 
Table 35: Average cell counts for the unweighted imputations by AN exposure group 
 
 
S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U
case 18 3 38 4 0 24 8 0 17 8 0 19 11 1 16 8 3 15 57 7 129
control 348 281 198 320 191 116 165 100 38 134 66 26 184 74 30 131 45 15 1282 757 423
case
control
case 49 8.5 - 25 2.2 - 23 1.7 - 25 2 - 25 2.5 - 21 4 - 168 21 -
control 450 360 - 387 227 - 186 111 - 149 72 - 201 81 - 139 48 - 1513 900 -
case
control
case 49 8.7 - 26 2 - 22 2.7 - 25 2 - 26 2 - 22 3 - 169 20.3 -
control 429 382 - 390 225 - 187 110 - 146 75 - 200 83 - 130 58 - 1481 932 -
case
control
case 50 8.2 - 26 1.6 - 23 1.7 - 25 2 - 26 2 - 23 3 - 171 18.1 -
control 442 369 - 394 220 - 190 107 - 151 71 - 204 78 - 137 50 - 1517 896 -
case
control
AN cumulative exposure group Total
Unexposed 1 2 3 4 5
100.0 100.0 91.7
O
rig
in
al
 s
ub
-c
oh
or
t
lung cancer
smoking prevalence  (%)
85.7
lung cancer OR 4.84 -
72.7 89.1
55.3 62.6 62.3 67.0 71.3 74.4 62.9
100.0
- - 4.42 0.92 4.81
q_
sm
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
85.3 92.0 93.1 92.8 90.9 83.5 88.9
55.6 63.0 62.6 67.4 71.3 74.3 62.7
lung cancer OR 4.65 6.72 8.00 6.25 4.03 1.75 4.76
89.0 94.0 92.7
m
_s
m
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
84.9
lung cancer OR 5.02 7.35
87.1 89.3
52.9 63.4 62.8 66.1 70.8 69.3 61.4
92.7
4.78 7.98 5.27 2.98 5.24
un
k_
sm
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
85.8 94.2 93.1 94.0 92.7 88.2 90.4
54.5 64.1 63.9 68.0 72.3 73.2 62.9
lung cancer OR 5.05 9.05 7.62 7.33 4.89 2.74 5.59  
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Table 36: Average cell counts for the weighted imputations by AN exposure group 
 
 
S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U S ~S U
case 18 3 38 4 0 24 8 0 17 8 0 19 11 1 16 8 3 15 57 7 129
control 348 281 198 320 191 116 165 100 38 134 66 26 184 74 30 131 45 15 1282 757 423
case
control
case 49 8.7 - 24 3.2 - 22 2.5 - 24 3 - 26 1.9 - 22 4 - 167 22.6 -
control 448 363 - 366 249 - 173 124 - 138 84 - 188 95 - 132 55 - 1443 970 -
case
control
case 50 8 - 24 3.1 - 22 2.6 - 24 3 - 25 2.1 - 23 2 - 168 20.8 -
control 428 383 - 365 249 - 174 123 - 135 87 - 186 96 - 122 65 - 1410 1003 -
case
control
case 50 8.4 - 24 3.4 - 22 2.2 - 24 3 - 25 2 - 23 3 - 168 21.1 -
control 440 370 - 366 249 - 170 127 - 134 88 - 183 99 - 124 63 - 1417 996 -
case
control
AN cumulative exposure group Total
Unexposed 1 2 3 4 5
100.0 100.0 91.7
O
rig
in
al
 s
ub
-c
oh
or
t
lung cancer
smoking prevalence  (%)
85.7
lung cancer OR 4.84 -
72.7 89.1
55.3 62.6 62.3 67.0 71.3 74.4 62.9
100.0
- - 4.42 0.92 4.81
q_
sm
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
84.9 88.4 89.8 89.8 93.1 85.9 88.1
55.3 59.5 58.1 62.1 66.4 70.5 59.8
lung cancer OR 4.57 5.17 6.33 5.37 6.79 2.55 4.95
89.4 90.2 92.3
m
_s
m
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
86.2
lung cancer OR 5.56 5.36
90.6 89.0
52.8 59.5 58.5 60.9 65.9 65.2 58.4
88.7
5.97 5.90 6.23 5.13 5.76
un
k_
sm
ok
e 
(a
ve
ra
ge
)
lung cancer
smoking prevalence  (%)
85.5 87.6 91.1 90.6 92.7 89.8 88.9
54.3 59.5 57.2 60.3 64.9 66.2 58.7
lung cancer OR 4.96 4.82 7.63 6.32 6.87 4.49 5.61  
 
 
 
5.2.2. Proportional hazards models for imputed datasets 
The imputed smoking status variables can now be modeled using SAS’ proportional 
hazards regression procedure to obtain the RRs in each quintile AN exposure, adjusted for 
smoking (Appendix A).  These results would be equivalent to the 1.6 reported in the NCI study 
(last column of row 4 of Table 1).  Figures 11-13 show the distribution of the lung cancer RRs in 
the upper quintile of AN exposure for each of the allocations, both unweighted and weighted.   
 
 
 
 62
0
5
10
15
20
1.2 1.3 1.4 1.5 1.2 1.3 1.4 1.5
q_smoke - unweighted q_smoke - weighted
Fr
eq
ue
nc
y
lung cancer RR
Graphs by gr_num
adjusted for smoking
Imputed Lung Cancer RRs in Upper Quintile of AN Exposure
 
 
Figure 11: Distribution of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted q_smoke variable 
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Figure 12: Distribution of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted m_smoke variable 
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Figure 13: Distribution of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted unk_smoke variable 
 
 
The histograms show that the distributions of these RRs appear to be more normally 
distributed than the overall RRs shown in Figures 5-10.  These smoking adjusted RRs also 
appear to be lower in the unweighted imputations than the weighted.  Because the weighting was 
designed to increase the overall lung cancer RR due to smoking, it seems that it has also slightly 
increased the lung cancer RR due to AN exposure in the upper quintile.  Figures 14-16 are 
boxplots of the same RRs for the 100 imputations for each scenario.  The reference line at 1.6 is 
the reported RR from the NCI study. 
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Figure 14: Boxplots of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted q_smoke variable 
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Figure 15: Boxplots of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted m_smoke variable 
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Figure 16: Boxplots of 100 imputed smoking adjusted RRs in the upper quintile of AN exposure for 
unweighted and weighted unk_smoke variable 
 
 
For all of the lung cancer RRs due to AN exposure in the upper quintile, the unweighted 
RRs are slightly lower than the weighted RRs.  None of the values approach the NCI’s value of 
1.6.  Table 37 shows the mean, minimum, maximum, and percentiles for the 100 imputed 
relative risks by allocation for each of the exposure quintiles. 
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Table 37: Descriptive statistics for the 100 imputed RRs by quintile of AN exposure and allocation 
 
 
10 25 50 75 90
unweighted 0.830 0.756 0.882 0.793 0.810 0.833 0.849 0.864
weighted 0.834 0.734 0.924 0.792 0.813 0.836 0.858 0.878
unweighted 0.791 0.713 0.854 0.751 0.772 0.794 0.812 0.829
weighted 0.787 0.679 0.883 0.737 0.763 0.791 0.814 0.838
unweighted 0.806 0.740 0.858 0.768 0.786 0.804 0.830 0.841
weighted 0.809 0.697 0.888 0.746 0.783 0.812 0.848 0.861
unweighted 1.056 0.976 1.124 1.011 1.029 1.059 1.080 1.097
weighted 1.095 1.002 1.180 1.042 1.068 1.091 1.126 1.146
unweighted 1.015 0.898 1.102 0.976 0.991 1.014 1.040 1.065
weighted 1.039 0.934 1.145 0.985 1.005 1.045 1.065 1.093
unweighted 1.016 0.885 1.130 0.969 0.988 1.019 1.042 1.062
weighted 1.075 0.947 1.206 1.004 1.034 1.082 1.106 1.139
unweighted 0.968 0.875 1.091 0.913 0.946 0.966 0.992 1.020
weighted 1.069 0.928 1.308 0.990 1.025 1.061 1.110 1.143
unweighted 0.952 0.843 1.063 0.902 0.915 0.951 0.985 1.014
weighted 1.054 0.882 1.230 0.956 1.012 1.056 1.101 1.152
unweighted 0.951 0.840 1.072 0.886 0.919 0.951 0.981 1.006
weighted 1.079 0.890 1.274 0.968 1.017 1.068 1.143 1.194
unweighted 0.839 0.762 0.908 0.798 0.819 0.838 0.862 0.877
weighted 0.812 0.716 0.905 0.763 0.780 0.812 0.838 0.863
unweighted 0.831 0.751 0.899 0.794 0.812 0.833 0.852 0.867
weighted 0.796 0.686 0.912 0.741 0.767 0.800 0.828 0.842
unweighted 0.821 0.721 0.895 0.776 0.798 0.820 0.849 0.869
weighted 0.817 0.662 0.897 0.754 0.786 0.828 0.858 0.874
unweighted 1.407 1.296 1.523 1.337 1.364 1.404 1.440 1.491
weighted 1.431 1.267 1.541 1.357 1.399 1.438 1.470 1.497
unweighted 1.390 1.256 1.540 1.321 1.363 1.390 1.420 1.451
weighted 1.405 1.236 1.548 1.318 1.363 1.419 1.446 1.475
unweighted 1.382 1.223 1.525 1.316 1.343 1.380 1.420 1.446
weighted 1.427 1.195 1.564 1.339 1.375 1.432 1.483 1.509
max percentiles
1 q_smoke
re -    
allocation
imputed 
smoking 
variable
type of 
imputation mean
m_smoke
3 unk_smoke
min
1
Quintile of 
AN 
Exposure
2
1
2
q_smoke
2 m_smoke
3 unk_smoke
3
1 q_smoke
2 m_smoke
3 unk_smoke
4
1 q_smoke
2 m_smoke
3 unk_smoke
5
1 q_smoke
2 m_smoke
3 unk_smoke
 
 
 
Figures 17-19 show the distriubution of the smoking adjusted RRs plotted across the AN 
exposure quintiles (1-5) for the different imputations and allocations.  It appears that the greatest 
difference in the unweighted and weighted plots within each reallocation scheme occurs for AN 
exposure quintile 3, where the RRs increase and show slightly more variation (boxplots are more 
spread out). 
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Figure 17: Boxplots of 100 imputed smoking adjusted RRs by quintile of AN exposure for unweighted and 
weighted q_smoke variable 
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Figure 18: Boxplots of 100 imputed smoking adjusted RRs by quintile of AN exposure for unweighted and 
weighted m_smoke variable 
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Figure 19: Boxplots of 100 imputed smoking adjusted RRs by quintile of AN exposure for unweighted and 
weighted unk_smoke variable 
 
 
 
5.2.3. Comparison of RRs from NCI study to imputed datasets 
The smoking adjusted RRs from the imputed data are compared with the NCI study 
results in Table 38.  The upper half of the table shows the results of the NCI study and the 
reanalysis using the q_smoke, m_smoke, and unk_smoke variables that were used to determine 
the smoking status.  Recall that in all four of these analyses, there was still a certain amount of 
missing smoking information in the dataset.  Therefore, subjects without smoking information 
dropped out of the analysis.  The biggest difference between these models is the lung cancer RR 
in the upper quintile of AN exposure for the unk_smoke variable, which treated the 111 
discordant observations as unknown.  Two of these were cases, so they would have been dropped 
from the analysis which decreased the number of strata in the risk set by two.  The other RRs for 
AN exposure quintiles 1-4 for unk_smoke are similar to the other three analyses with the missing 
smoking histories.   
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The bottom half of Table 38 shows the mean values of the imputed RRs by cumulative 
AN exposure group for the different imputations and allocations.  The RR in the lowest quintile 
of AN exposure jumps from 0.3 to around 0.8 for all reallocations.  Quintile 2’s RRs also see a 
slight increase from 0.8 to 1.0.  Exposure groups 3 and 4 are similar.  The upper quintile values 
are slightly lower, ranging from a minimum of 1.382 for the unk_smoke unweighted scenario to 
a maximum of 1.431 in the q_smoke weighted.  The values from Table 38 are plotted in Figures 
20-23. 
 
Table 38: Smoking adjusted lung cancer RRs by quintile of AN exposure and allocation 
 
 
1 2 3 4 5
NCI study - 0.3 0.8 1 0.9 1.6
q_smoke - 0.308 0.847 0.921 0.839 1.555
m_smoke - 0.289 0.809 0.903 0.827 1.518
unk_smoke - 0.296 0.756 0.921 0.853 1.388
q_smoke unweighted 0.830 1.056 0.968 0.839 1.407
q_smoke weighted 0.834 1.095 1.069 0.812 1.431
m_smoke unweighted 0.791 1.015 0.952 0.831 1.390
m_smoke weighted 0.787 1.039 1.054 0.796 1.405
unk_smoke unweighted 0.806 1.016 0.951 0.821 1.382
unk_smoke weighted 0.809 1.075 1.079 0.817 1.427
a Mean RR values shown for imputed data
AN exposure quintile
Imputed missing 
smoking 
informationa
Analysis with 
missings
lung cancer RR, adjusted for smoking
Description
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Figure 20: Smoking adjusted lung cancer RR by quintile of AN exposure for analysis models that included 
unknown smoking histories 
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Figure 21: Smoking adjusted lung cancer RR by quintile of AN exposure for q_smoke imputations 
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Figure 22: Smoking adjusted lung cancer RR by quintile of AN exposure for m_smoke imputations 
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Figure 23: Smoking adjusted lung cancer RR by quintile of AN exposure for unk_smoke imputations 
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Figure 20 compares the three smoking status allocation schemes against the original NCI 
data.  The missing values were included in these analyses, only the discordant smoking histories 
were reassigned.  The plots are similar; the only notable difference is the slightly lower RR in the 
upper quintile of AN exposure for the unk_smoke allocation.  Figures 21-23 show the mean 
values of the imputed lung cancer RRs (adjusted for smoking) by AN exposure quintile for each 
of the three allocation schemes.  The original NCI study results are also shown in each figure.  
All plots of the imputed mean values show an increase in smoking adjusted RRs for quintiles 1 
and 2 and a slight decrease in the upper quintile of AN exposure as compared to the NCI values.  
Lung cancer RRs in exposure quintiles 3 and 4 are similar for the imputations and the original 
study results. 
 
5.2.4. Comparison of full cohort adjusted RRs from NCI study to imputed datasets 
The final step in the reanalysis is to adjust the full cohort lung cancer RRs in the upper 
quintile of AN exposure.  This adjustment involves applying the same proportional change 
observed in the sub-cohort smoking adjusted and unadjusted RRs to the full cohort unadjusted 
relative risk.  In the NCI study, the change in the upper quintile of AN exposure for the full 
cohort, unadjusted to adjusted, was a drop of 1.5 to 1.4 (first and last rows of Table 1).  The 
proportional change observed in the smoking sub-cohort, unadjusted to adjusted, was 1.7 to 1.6.  
Applying this same decrease to the full cohort resulted in the adjusted RR of 1.4 in the upper 
quintile of AN exposure.  Table 39 shows the comparisons of the relative risks and the final 
adjustment for smoking. 
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Table 39: Final adjustments of the full cohort lung cancer RRs in the upper quintile of AN exposure 
 
 
Unadjusted Adjusted Change Unadjusted Adjusted
Design Actual Mean Median for smokingd for smoking (Adj/Unadj) for smoking for smokingc
NCIa 3.6 - - 1.7 1.6 0.94 1.5 1.4
NCI reanalysis 3.87 - - 1.73 1.55 0.896 1.5 1.34
q_smoke 3.87 - - 1.73 1.55 0.896 1.5 1.34
m_smoke 4.22 - - 1.73 1.52 0.875 1.5 1.31
unk_smoke 4.40 - - 1.58 1.39 0.876 1.5 1.31
q_smoke, unweighted - 4.17 3.93 1.54 1.41 0.913 1.5 1.37
q_smoke, weighted - 5.29 4.45 1.54 1.43 0.928 1.5 1.39
m_smoke, unweighted - 4.64 4.33 1.54 1.39 0.902 1.5 1.35
m_smoke, weighted - 6.22 5.21 1.54 1.40 0.911 1.5 1.37
unk_smoke, unweighted - 4.88 4.41 1.54 1.38 0.896 1.5 1.34
unk_smoke, weighted - 6.37 5.62 1.54 1.43 0.926 1.5 1.39
a Results of original study only shown to one decimal place
b RRs shown are the mean values excpet as noted
c Adjusted value = (Unadjusted for smoking) x (change)
d With information on smoking
Sub-cohort Full cohort
Lung cancer RR in upper 
quintile of cumulative AN 
Imputed 
missingsb
Lung cancer RR in upper 
quintile of cumulative AN Overall lung cancer RR due to smoking
Analysis with 
missing data
 
 
 
The first five rows show the results of the proportional hazards model run for the dataset 
that included individuals with missing smoking histories.  The next portion of the table shows the 
mean and median of the overall lung cancer RRs for the six imputation schemes.  The overall 
lung cancer RRs due to smoking do not achieve the desired increase to 8.0-10.0, with mean 
values ranging from 4.17 to 6.37 with the imputed missings.  Of all designs, the overall smoking 
RR is highest in the un_smoke, weighted reallocation, with a mean of 6.37 and median of 5.62. 
In order to apply the proportional adjustment to the full cohort, the unadjusted RRs in the 
upper quintile of AN exposure had to be found for the sub-cohort.  These models are unadjusted 
for smoking, but are restricted to include only those individuals with observed smoking 
information.  For the NCI analysis with the missing data and the smoking status allocations 
q_smoke, and m_smoke, this unadjusted RR is 1.73.  These should be equal, because the number 
of missings is equal for these designs.  The RR for unk_smoke, which had 111 more individuals 
with missing information, drops to 1.58.  In the imputed designs, where smoking information 
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was available for all employees (imputed or originally known), the model only had to be run 
once to obtain an unadjusted RR of 1.54. 
The ‘change’ column in Table 39 calculates the proportional change from the adjusted to 
the unadjusted relative risks.  This is then multiplied (the method used by NCI) to the full cohort 
unadjusted RR in the upper quintile to obtain the full cohort adjusted RR due to AN exposure in 
the highest exposure group.  The full cohort adjusted RRs in the upper quintile of AN exposure 
range from 1.31 to 1.39 compared to the NCI reported RR of 1.4.  The lowest adjusted value of 
1.31 actually occurs in the m_smoke and unk_smoke designs that did not involve any 
imputations. 
 
6. DISCUSSION 
 
The goal of increasing the overall lung cancer RR in ever- versus never-smokers was not 
achieved.  The histograms in Figures 5, 7, and 9 do show some values that lie in the desired 
range of 8.0-10.0, so there are some imputations that resulted in the desired increase, although 
the mean and median RRs were not significantly greater than the original 3.6.  The histograms 
also show that weighted imputations are not, except for a few outlying RRs, very much higher 
than the RRs for the unweighted imputations.  This is most likely due to the frequency weights 
used for the controls.  From Table 31, it can be seen that the weighted controls make up a much 
smaller proportion of the complete controls than do the cases.  With only 64 complete cases, a 
frequency weight of 10 has much more of an effect than applying a frequency weight of 10 
applied to 2039 complete controls.  In order to force many more controls to be never-smokers, 
frequency weights of 10, 20, 40, 60, 80, and 100, for example, could be applied to the controls to 
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see if this overall relative risk could be increased even further.  The case weights could also be 
increased, but because there are fewer cases and since most of the incomplete cases were 
assigned as ever-smokers already with the weights in Table 31, there would not be as much to 
gain by increasing the case weights as there would be with increasing the control weights. 
The slight change to the lung cancer RR in the upper quintile of AN exposure after 
adjustment for smoking (1.5 to 1.4 reported by the NCI) was also not significantly different in 
any of the analyses when compared to the original study results.  Although the sub-cohort 
smoking adjusted RRs decreased from 1.55 (reanalysis of NCI results) to 1.39-1.43 for the 
different allocations and imputation of the smoking histories, the full cohort smoking adjusted 
numbers were similar.  This slight decrease in the sub-cohort adjusted RRs was counteracted by 
the decrease of the sub-cohort unadjusted RRs from 1.73 to 1.54.  The proportional changes are 
therefore not as great, resulting in the similar full cohort adjusted values.  For example, for the 
unk_smoke, weighted imputation design, the sub-cohort smoking adjusted mean RR was 1.38.  
The change is then 1.38/1.54, or 0.896.  When multiplied to the unadjusted full cohort value of 
1.5 (from NCI), the final adjusted RR is 1.34.  This is not significantly less than the original NCI 
study result of 1.4. 
From Table 39, the best combination of an increased RR overall and a lower adjusted RR 
in the upper quintile of exposure appears to be the m_smoke, weighted design.  The mean overall 
RR is 6.22 and the full cohort RR adjusted for smoking is 1.37.  But this value of 1.37 is very 
close to the NCI study (1.4) and could again be due to rounding. 
Although the analysis of the imputed datasets did not yield results that were significantly 
different from the original NCI study, one very interesting result can be seen in Figures 21-23.  
The plots of the mean RRs for the three allocations appear to be much flatter than the plot of the 
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NCI study results, visually indicating less of an exposure-response trend for the imputed data 
than the analysis with the missing smoking histories.  The effect is most pronounced in the 
lowest quintile of AN exposure, where the NCI RR of 0.3 increased to a range of 0.79 to 0.83 for 
the imputed analyses.  The RR in exposure quintile 2 increased from 0.8 to slightly more than 
1.00 for the imputed designs.  The RRs in quintiles 3 and 4 are similar between the imputed and 
original designs.  The upper quintile of AN exposure decreased from the NCI value of 1.6 to an 
average of 1.4 for the imputations.  All analyses with the imputed missing smoking information 
have exposure-response plots that are pivoted clockwise around quintile 3, raising the RRs for 
quintiles 1 and 2 while lowering them for quintiles 4 and 5.  When the NCI plot is compared with 
any of the imputed plots in Figures 21-23, the exposure-response trend is much less pronounced 
in the imputed designs than the original NCI results.  And although the upper quintile of AN 
exposure RRs did not change markedly with the imputed data, analysis with the missing data 
appears to have had an effect on the lower quintiles of exposure, regardless of weighting or 
allocation. 
Several areas could be considered for follow-up.  Because the observed deaths by AN 
exposure quintile could not be reproduced exactly from the original study data, the authors could 
be contacted to try and resolve this issue.  Additionally, the issue of rounding could be discussed.  
Because the NCI results are based on applying a proportionate change to a relative risk and then 
applying this change to an unadjusted RR, it would be important to have these values carried to 2 
or possibly 3 decimal places so they could be more accurately compared with this reanalysis. 
Another possible area for further study might be to carry out the proportional hazards 
modeling with only those smoking status imputations that yielded the high overall RRs due to 
smoking.  For example, from Table 34 the 75th percentile RR for the unk_smoke, weighted 
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allocation was 8.53.  Because these values could possibly occur outside of chance alone, they 
could be observed in a dataset and not be outside the realm of believability.  The proportional 
hazards model could be run on just these observations, the estimates averaged, and the adjusted 
and unadjusted comparisons could be performed.  But this selective process would defeat the 
purpose of doing the imputations and could cast doubt on any results. 
One other approach would be to assume that there is no smoking information at all and 
perform a Monte-Carlo simulation as proposed by Steenland and Greenland (2004).  They have 
developed a method of analyzing occupational cohorts where smoking information was not 
gathered to determine if any confounding has occurred.  The method involves assuming a 
distribution of the workers’ smoking habits (which could be obtained from the sub-cohort), the 
distribution of lung cancer risk due to smoking, and an added bias parameter.  In the NCI study, 
this would lead to a distribution of the lung cancer relative risks due to AN exposure, 
hypothetically adjusted for smoking.  This could be compared to the full cohort analysis that was 
unadjusted for smoking to determine if any confounding due to smoking was likely.  This 
method could be applied to the entire cohort as if no smoking information was available and the 
results could be compared with the NCI sub-cohort analysis to see if they agree. 
Another step might involve a more detailed analysis if the individuals with missing 
smoking information.  The amount of follow-up, for example, might be different for the 
individuals with missing data than those who had smoking histories. 
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7. CONCLUSIONS 
 
Because the reported overall lung cancer RR of 3.6 appeared to be much too low and also 
due to the large amount of missing smoking information, particularly in the cases, it would 
appear at first glance that the results of the NCI study could be questioned.  There was 
disagreement between some of the smoking histories and the possibility of individuals being 
misclassified could also have occurred.  But from the results of the reanalysis with the 
imputations, it appears that the adjusted lung cancer relative risk in the highest quintile of AN 
exposure is in the range of that reported NCI study.  The adjusted RRs are lower, but may be 
closer (or lower) due to the rounding used by NCI.  Differences in the observed deaths and some 
of the slight differences in RRs between the NCI study and the results presented here must also 
be considered.  Although a smoking adjusted RR in the upper quintile that drops from 1.5 to 1.31 
after adjustment is a 13% decrease, it would be difficult to say these results are more accurate 
than those presented in the NCI paper. 
From the reanalysis of the designs with the three allocation schemes and the two types of 
imputations (unweighted and weighted), it appears that raising the overall lung cancer relative 
risk due to smoking and significantly lowering the smoking adjusted lung cancer RR in the upper 
quintile of AN exposure are not plausible given the scenarios and weighting used in this 
reanalysis.   When the overall RR is increased by the weighting, the RRs in the upper quintile 
also increase.  Unweighted imputation values have the desired lower RR in the upper quintile, 
adjusted for smoking, but when applied to the full cohort, this decrease is not as dramatic and is 
close to the adjusted value reported in the NCI study. 
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It does appear as if the original NCI results were biased in the lower quintiles of AN 
exposure, where the lung cancer RRs changed significantly when the imputed data were 
analyzed.  This change in the lower quintiles changed the appearance of the exposure-response 
plots, indicating less of a trend than was observed using the original NCI results.  This flattening 
of the exposure-response curve, when combined with the only slightly elevated lung cancer RR 
in the upper quintile of AN exposure, provide evidence against an association of elevated lung 
cancer risk due to high AN exposures. 
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APPENDIX A 
EXAMPLE SAS PROGRAM USED IN ANALYSIS 
* The following program is typical of the programs used to compute the * RRs 
for the reproduction of the NCI results and to calculate the RRs * for the 
various imputations and weighting schemes. ; 
 
* This program opens the original NCI dataset, smkanal, and reads in 
* the appropriate text file for the smoking status information from  
* Stata. ; 
 
* The program below shows the weighted q_smoke allocation, but the  
* program is identical for q_smoke, m_smoke, unk_smoke analysis with  
* the missing data, and also for the the q_smoke, m_smoke, unk_smoke  
* unweighted and weighted imputations.  The only differences are the  
* name of the Stata text file read into SAS and the variable names.   
 
* Also, the imputed results are sent to tab delimited text files for  
* further analysis, whereas the analysis with the missing data did not  
* have to iterate through 100 imputations. ; 
 
* The risk set creation and proportional hazards procedure were taken  
* from the proportional hazards macro from Ichikawa and Barlow (1998); 
/* 
=================================================================== 
  Name: CASECOH.SAS (Survival Analysis with Robust Variance Matrix) 
  Version: 1.0.2 
  Authors: Laura Ichikawa and William Barlow 
           Center for Health Studies, Group Health Cooperative  
           Seattle, WA 
  Origin date: January 1996 
  Revision date(s): March 1998 
 
  The IML portion of the program is derived from the SAS sample 
  program PHR610EX.SAS in the SAS Sample Library. 
 
  =================================================================== 
*/ 
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* Open NCI dataset, SMKANAL ; 
data nci_subco ; 
 set 'c:\mikes files\thesis\smkanal'  
  (drop = avg_an cigsday cigsday2 cumderml cuminhal dermal  
  dermconc dermfreq drm16-drm68 drmdays3 dydrm16-dydrm68  
  dyphy16-dyphy68 inhaled max16-max68 phy16-phy68 phydays2 
  phys_exp cum_an ) ; 
* Unneccessary variables were dropped ; 
* Create id variable ; 
 id = substr(cohort,2,5) ; 
* Create variable to match with SMOKECUM - NCI Excel dataset ; 
 plnt_id = substr(cohort,1,6) ; 
run ; 
 
* Read in the data from the stata imputed file, in this case the   
q_smoke weighted imputations.  Only the employee ID and the imputed smoking 
statuses are needed from Stata. ; 
data from_stata ; 
infile 'c:\mikes 
files\thesis\Thesis_Jul_05\imputations\imputed_smoking_from_stata_qsmk_
mc02.txt'  
  dlm = '09'X firstobs = 2 missover lrecl = 3000 ; 
 input cohort $ smk_q1-smk_q100 ; 
run ; 
 
* Sort both datasets to merge the imputed smoking statuses with the original 
NCI ata d ; 
proc sort data = from_stata ; 
 by cohort ; 
run ; 
proc sort data = nci_subco ; 
 by cohort ; 
run ;  
data nci_subco_imp ; 
 merge from_stata nci_subco ; 
run ; 
 
* Will now redo the risk sets with the imputed info ; 
 
* Create logic to get the event times ; 
data events_imp ; 
 set nci_subco_imp ; 
 if original = 1 and vital in (1 2) then eagedays = 
datdif(dob,dod,'actual') ; 
 if vital in (1 2 3 ) and original ne 1 then eagedays = 
datdif(dob,dod,'actual') ; 
 if vital = 0 then eagedays = datdif(dob,exitdate,'actual') ; 
 eventage = eagedays/365.25 ; 
 age_strt = datdif(dob,hiredate,'actual')/365.25 ; 
 age_stop = datdif(dob,exitdate,'actual')/365.25 ; 
run ; 
proc sort ; 
 by ca_case original vital ; 
run ; 
proc sort ; 
 by eventage ; 
run ; 
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* Create the risk set ; 
 data one_imp ; 
    retain strat 0 ; 
    set events_imp ; 
    if vital in (1 3) then do ; 
       strat + 1 ; 
       evnttime= eventage ; 
       t=1   ;
       wt=1 ; 
       output ; 
       do i=_n_+1 to n ; 
          set events_imp point=i nobs=n ; 
          if original=1 and (age_strt lt evnttime le age_stop) 
          then  ; do
             t=2 ; 
             wt=10 ;  /* 10% subcohort */ 
             output ; 
          end ; 
       end ; 
 end ;    
 run ; 
 
/*  
   The risk set formation above was taken from the CASECOH.SAS macro  
   cited at the beginning of the program (Ichikawa and Barlow 1998). 
   Barlow (1994) described the weights that reflect subcohort  
   membership. 
   Controls in the subcohort are weighted inversely proportional to the  
   sampling fraction. In this case the sampling fraction is 10%, so the  
   weight is 10. 
 */  
 
* No have to get the AN exposure for the employees ; 
data dates_imp ; 
 set one_imp ; 
 evage = evnttime ; 
 evdays = evnttime*365.25 ; 
 if expdate ne . then exage =  
datdif(dob,expdate,'actual')/365.25 ; 
 evdate = dob+evdays ; 
 rndage = floor(evage) ; 
* need to be able to handle the events past 68 years ; 
 if rndage ge 68 then rndage = 67 ; 
 ev_yr_exp_days = floor((evage-rndage)*365.25) ; 
 dempd = datdif(hiredate,evdate,'actual') ; 
 if expdate ne . then days = datdif(expdate,evdate,'actual') ; 
run ; 
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* Create arrays to allow for caclulation of exposure.  The original NCI  
 data had exposure by year for each employee, which has to be  
 converted to the exact days elasped within a year. ; 
 
 
* Exposure calculations follow the method outlined by Marsh et al. (1998) ; 
 
data calc_exp_imp ; 
 set dates_i  mp ; 
 array wrk {16:68} wrk16-wrk68 ; 
 array dyexp {16:68} dyexp16-dyexp68 ;  
 array expo {16:68} exp16-exp68 ;  
 array aie {16:68} aie16-aie68 ; 
 cum_an = 0 ; 
 cum_wrk = 0 ; 
 cum_exp = 0 ; 
* Calculate aie from given exposures  ; 
 do i = 16 to 68 ; 
  if dyexp{i} = 0 then dyexp{i} = -1 ; 
  aie{i} = expo{i}/dyexp{i} ; 
  if aie{i} le 0 en aie{i} = 0 ; th
  if dyexp{i} = -1 then dyexp{i} = 0 ; 
 end ; 
run ; 
* Get actual exposure at event time ; 
data actual_exp_imp ; 
 set calc_exp_imp ; 
 array wrk {16:68} wrk16-wrk68 ; 
 array dyexp {16:68} dyexp16-dyexp68 ;  
 array expo 16 68} exp16-exp68 ;  { :
 array aie {16:68} aie16-aie68 ; 
 array act_exp {16:68} act_exp16-act_exp68 ; 
 exp_days = 0 ; 
 wrk_days = 0 ; 
 cum_an = 0 ; 
 do i = 16 to (rndage-1) ; 
  act_exp{i} = aie{i}*dyexp{i} ; 
 end ; 
* do loop if exposure age is before the event ; 
 if exage = 0 or exage lt evage then do ; 
 if dyexp{rndage} = 0 or dyexp{rndage} lt ev_yr_exp_days  
  then dyexp{rndage} = dyexp{rndage} ; 
  else dyexp{rndage} = ev_yr_exp_days ; 
 end ; 
* need logic for the first exposure year, if the exp is 
 after the event ; 
 if exage ne 0 and exage gt evage then dyexp{rndage} = 0 ; 
if evage gt exage and floor(exage) = floor(evage) then  
dyexp{rndage} = days ; 
* now get act exp for the event year ; 
 act_exp{rndage} = dyexp{rndage}*aie{rndage} ; 
* make the rest of the exposures zero ; 
  do i = (rndage+1) to 68 ; 
  dyexp{i} = 0 ; 
  act_exp{i} = aie{i}*dyexp{i} ; 
 end ; 
 do i = 16 to 68 ;   
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  cum_an = cum_an + act_exp{i} ; 
  exp_days = exp_days + dyexp{i} ; 
  wrk_days = wrk_days + wrk{i} ; 
 end ; 
run ; 
 
* Create exposure quintiles ; 
data risk_imp ; 
 set actual_exp_imp  
drop = dyexp16-dyexp68 exp16-exp68 wrk16-wrk68  
  act_exp16-act_exp68 aie16-aie68) ; 
 ancum =(5/7)*cum_an/365.25 ; 
* create dummy variables for ancum ; 
 ancum1= 0 ; 
 ancum2= 0 ; 
 ancum3= 0 ; 
 ancum4= 0 ; 
 ancum5= 0 ; 
* NCI original quintiles ; 
 if ancum eq 0 then ancum1 = 0 ; 
 if ancum gt 0 nd ancum lt .13 hen ancum1 = 1 ;  a  t
 if ancum ge .13 and ancum lt .57 then ancum2 = 1 ; 
 if ancum ge .57 and ancum lt 1.50 then ancum3 = 1 ; 
 if ancum ge 1.50 and ancum lt 8.0 then ancum4 = 1 ; 
 if ancum ge 8.0 then ancum5 = 1 ; 
run ; 
 
* Calculate the Overall lung cancer RR due to smoking ; 
* need to iterate by the number at the end to get all estimates in one  
file ; 
%macro impute ; 
%do i = 1 %to 100 ; 
proc phreg data = risk_imp outest = q_imp&i noprint ;  
   model t*t(2) = smk_q&i ;  
   freq wt ;  
   strata strat ;  
   id cohort ;  
run ; 
%end ; 
%mend impute ; 
%impute ; 
 
%macro comb_imp ; 
 %do n= 2 %to 100 ; 
data q_imp1 ; 
 set q_imp1 q_imp&n ; 
run ; 
%end ; 
%mend ; 
%comb_imp ; 
proc print data = q_imp1 ; 
run ; 
 
* Combine results of imputations ; 
data unadj_rr ; 
 set q_imp1 ; 
 array smk_q {1:100} smk_q1-smk_q100 ; 
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 unadj_lung = 0 ; 
 smk_q_imp = _n_ ; 
 do i = 1 to 100  ; 
  if smk_q {i} = . then smk_q {i} = 0 ; 
  unadj_lung = unadj_lung + smk_q {i} ; 
 end ; 
 unadj_lung_rr = exp(unadj_lung) ; 
 drop i _ties_ _type_ _status_ _name_ smk_q1-smk_q100 _lnlike_  ; 
run ; 
proc print data = unadj_rr ; 
run ; 
proc sort ; 
 by unadj_lung_rr ; 
run ; 
* Ge  descriptit ves for the 100 imputed RRs ; 
proc univariate ; 
 histogram unadj_lung_rr ; 
run ; 
* Export the values to a text file ; 
proc export data = unadj_rr outfile = 'c:\mikes  
files\thesis\Thesis_Jul_05\imputations\q_smk_overallRR_imps.txt' 
 dbms = tab replace ; 
run ; 
 
* NCI paper reproductions ; 
* Create variables needed in model ; 
data tab9 ; 
 set risk_imp ; 
* create new race var, put all unknowns into 0 ; 
 if race2 = 9 then race2 = 0 ; 
 caltime = dobyr + evage ; 
run ; 
 
* table 9 line 2, cum exp for full smoking subcohort not adjusted for  
smoking ;  
 
proc phreg data = tab9 outest = est1 ;  
   model t*t(2) = caltime ancum1 ancum2 ancum3 ancum4 ancum5 gender race2 ;  
   freq wt ;  
   strata strat ;  
   id cohort ;  
run ; 
proc print data = est1 ; 
run ; 
 
* table 9 line 3, cum exp for full smoking subcohort with 
smoking info, not adjusted for smoking ;  
 
proc phreg data = tab9 outest = est2 ;  
   model t*t(2) = caltime ancum1 ancum2 ancum3 ancum4 ancum5 gender race2 ;  
   freq wt ;  
   strata strat ;  
   id cohort ;  
   where smkstat ne 9 ; 
run ; 
proc print data = est2 ; 
run ; 
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* table 9 line 4, cum exp for full smoking subcohort adjusted for smoking ;  
 
proc phreg data = tab9 outest = est3 ;  
   model t*t(2) = smkstat caltime ancum1 ancum2 ancum3 ancum4 ancum5 gender 
race2 ;  
   freq wt ;  
   strata strat ;  
   id cohort ;  
   where smkstat ne 9 ; 
run ; 
proc print data = est3 ; 
run ; 
 
* Rerun the models using the 100 imputed smoking status variables ; 
* Use the different smoking imputations - NCI table 9 line 4 ; 
 
%macro tab9_q ; 
%do i = 1 %to 100 ; 
proc phreg data = tab9 outest = q_t9&i  ;  
   model t*t(2) = smk_q&i caltime ancum1 ancum2 ancum3 ancum4 ancum5 gender 
race2 ;  
   freq wt ;  
   strata strat ;  
   id cohort ;  
run ; 
%end ; 
%mend ; 
%tab9_q  ; 
 
%macro comb_t9_q ; 
 %do n= 2 %to 100 ; 
data q_t91 ; 
 set q_t91 q_t9&n ; 
run ; 
%end ; 
%mend ; 
%comb_t9_q ; 
proc print data = q_t91 ; 
run ; 
 
* array to get results in columns ; 
data comb ; 
 set q_t91 ; 
 array smk_q {1:100} smk_q1-smk_q100 ; 
 lung_beta = 0 ; 
 smk_q_imp = _n_ ; 
 ancum_1 = exp(ancum1) ; 
 ancum_2 = exp(ancum2) ; 
 ancum_3 = exp(ancum3) ; 
 ancum_4 = exp(ancum4) ; 
 ancum_5 = exp(ancum5) ; 
 do i = 1 to 100  ; 
  if smk_q {i} = . then smk_q {i} = 0 ; 
  lung_beta = lung_beta + smk_q {i} ; 
 end ; 
 lung_rr = exp(lung_beta) ; 
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 drop i _ties_ _type_ _status_ _name_ caltime smk_q1-smk_q100 
  gender race2 _lnlike_ ancum1-ancum5 lung_beta ; 
run ; 
proc print data = comb ; 
run ; 
proc sort ; 
 by ancum_5 ; 
run ; 
 
* Print descriptives for upper quintile of AN exposure only ; 
proc univariate ; 
 histogram ancum_5 ; 
run ; 
 
* Se d datan  to tab delimited file ; 
proc export data = comb  
outfile = 'c:\mikes 
files\thesis\Thesis_Jul_05\imputations\q_smk_table9_imps.txt' 
  dbms = tab replace ; 
run ; 
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